BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, Tellier R, Draker R, Adachi D, Ayers M, Chan AK, Skowronski DM, Salit I, Simor AE, Slutsky AS, Doyle PW, Krajden M, Petric M, Brunham RC, McGeer AJ;  National Microbiology Laboratory; Canada;  Canadian Severe Acute Respiratory Syndrome Study Team. Identification of severe acute respiratory syndrome in Canada. N Engl J Med. 2003;348:1995-2005. [PMID: 12671061 DOI: 10.1056/nejmoa030634] [Cited by in Crossref: 696] [Cited by in F6Publishing: 520] [Article Influence: 36.6] [Reference Citation Analysis]
Number Citing Articles
1 Vogt TM, Guerra MA, Flagg EW, Ksiazek TG, Lowther SA, Arguin PM. Risk of severe acute respiratory syndrome-associated coronavirus transmission aboard commercial aircraft. J Travel Med 2006;13:268-72. [PMID: 16987125 DOI: 10.1111/j.1708-8305.2006.00048.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
2 Wilder-Smith A, Leong HN, Villacian JS. In-flight transmission of Severe Acute Respiratory Syndrome (SARS): a case report. J Travel Med 2003;10:299-300. [PMID: 14531986 DOI: 10.2310/7060.2003.2737] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
3 Ohara H, Pokhrel BM, Dahal RK, Mishra SK, Kattel HP, Shrestha DL, Haneishi Y, Sherchand JB. Fact-finding Survey of Nosocomial Infection Control in Hospitals in Kathmandu, Nepal-A Basis for Improvement. Trop Med Health 2013;41:113-9. [PMID: 24155652 DOI: 10.2149/tmh.2013-03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Nicholls JM, Butany J, Poon LL, Chan KH, Beh SL, Poutanen S, Peiris JS, Wong M. Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med 2006;3:e27. [PMID: 16379499 DOI: 10.1371/journal.pmed.0030027] [Cited by in Crossref: 102] [Cited by in F6Publishing: 99] [Article Influence: 6.4] [Reference Citation Analysis]
5 Ng ML, Lee JW, Leong ML, Ling AE, Tan HC, Ooi EE. Topographic changes in SARS coronavirus-infected cells at late stages of infection. Emerg Infect Dis 2004;10:1907-14. [PMID: 15550199 DOI: 10.3201/eid1011.040195] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
6 Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343. [PMID: 16968120 DOI: 10.1371/journal.pmed.0030343] [Cited by in Crossref: 694] [Cited by in F6Publishing: 615] [Article Influence: 46.3] [Reference Citation Analysis]
7 Hwang SW, Cheung AM, Moineddin R, Bell CM. Population mortality during the outbreak of Severe Acute Respiratory Syndrome in Toronto. BMC Public Health 2007;7:93. [PMID: 17535440 DOI: 10.1186/1471-2458-7-93] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
8 Lai LWC, Chau KW, Ho DCW, Lin VYY. Impact of Political Incidents, Financial Crises, and Severe Acute Respiratory Syndrome on Hong Kong Property Buyers. Environ Plann B Plann Des 2006;33:413-33. [DOI: 10.1068/b31125a] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Schwartz DA, Graham AL. Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses 2020;12:E194. [PMID: 32050635 DOI: 10.3390/v12020194] [Cited by in Crossref: 380] [Cited by in F6Publishing: 333] [Article Influence: 190.0] [Reference Citation Analysis]
10 Lee J, Holden L, Fung K, Danjoux C, Chow E, Gillies C. Impact of severe acute respiratory syndrome on patient access to palliative radiation therapy. Support Cancer Ther 2005;2:109-13. [PMID: 18628197 DOI: 10.3816/SCT.2005.n.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
11 Ebihara T, Endo R, Kikuta H, Ishiguro N, Ishiko H, Hara M, Takahashi Y, Kobayashi K. Human metapneumovirus infection in Japanese children. J Clin Microbiol 2004;42:126-32. [PMID: 14715742 DOI: 10.1128/JCM.42.1.126-132.2004] [Cited by in Crossref: 127] [Cited by in F6Publishing: 65] [Article Influence: 7.1] [Reference Citation Analysis]
12 Rainer T, Cameron P, Smit D. Should Differential White Cell Counts be Reported as Percentages or Absolute Counts in Patients with Severe Acute Respiratory Syndrome? Hong Kong Journal of Emergency Medicine 2004;11:12-5. [DOI: 10.1177/102490790401100103] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Robertson CA, Lowther SA, Birch T, Tan C, Sorhage F, Stockman L, McDonald C, Lingappa JR, Bresnitz E. SARS and pregnancy: a case report. Emerg Infect Dis. 2004;10:345-348. [PMID: 15030710 DOI: 10.3201/eid1002.030736] [Cited by in Crossref: 95] [Cited by in F6Publishing: 86] [Article Influence: 5.3] [Reference Citation Analysis]
14 Byington CL, Ampofo K, Stockmann C, Adler FR, Herbener A, Miller T, Sheng X, Blaschke AJ, Crisp R, Pavia AT. Community Surveillance of Respiratory Viruses Among Families in the Utah Better Identification of Germs-Longitudinal Viral Epidemiology (BIG-LoVE) Study. Clin Infect Dis 2015;61:1217-24. [PMID: 26245665 DOI: 10.1093/cid/civ486] [Cited by in Crossref: 122] [Cited by in F6Publishing: 111] [Article Influence: 17.4] [Reference Citation Analysis]
15 Hwang DM, Chamberlain DW, Poutanen SM, Low DE, Asa SL, Butany J. Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol. 2005;18:1-10. [PMID: 15272286 DOI: 10.1038/modpathol.3800247] [Cited by in Crossref: 209] [Cited by in F6Publishing: 186] [Article Influence: 12.3] [Reference Citation Analysis]
16 Tong S, Lingappa JR, Chen Q, Shu B, LaMonte AC, Cook BT, Birge C, Chern SW, Liu X, Galloway R, Mai le Q, Ng WF, Yang JY, Butany J, Comer JA, Monroe SS, Beard SR, Ksiazek TG, Erdman D, Rota PA, Pallansch MA, Anderson LJ. Direct sequencing of SARS-coronavirus S and N genes from clinical specimens shows limited variation. J Infect Dis 2004;190:1127-31. [PMID: 15319863 DOI: 10.1086/422849] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
17 da Silva J, Silva C, Alexandre B, Morgado P. Health Literacy of the Inland Population in Mitigation Phase 3.2 of the COVID-19 Pandemic in Portugal: A Descriptive Cross-Sectional Study. Port J Public Health. [DOI: 10.1159/000511216] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Geller C, Varbanov M, Duval RE. Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies. Viruses 2012;4:3044-68. [PMID: 23202515 DOI: 10.3390/v4113044] [Cited by in Crossref: 204] [Cited by in F6Publishing: 165] [Article Influence: 20.4] [Reference Citation Analysis]
19 Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, Murphy BR, Rappuoli R, Lanzavecchia A. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 2004;10:871-5. [PMID: 15247913 DOI: 10.1038/nm1080] [Cited by in Crossref: 494] [Cited by in F6Publishing: 479] [Article Influence: 27.4] [Reference Citation Analysis]
20 Nie Y, Wang G, Shi X, Zhang H, Qiu Y, He Z, Wang W, Lian G, Yin X, Du L, Ren L, Wang J, He X, Li T, Deng H, Ding M. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J Infect Dis 2004;190:1119-26. [PMID: 15319862 DOI: 10.1086/423286] [Cited by in Crossref: 96] [Cited by in F6Publishing: 99] [Article Influence: 5.3] [Reference Citation Analysis]
21 Sweileh WM. Global research trends of World Health Organization's top eight emerging pathogens. Global Health 2017;13:9. [PMID: 28179007 DOI: 10.1186/s12992-017-0233-9] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 17.6] [Reference Citation Analysis]
22 Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome Coronavirus. Semin Respir Crit Care Med. 2020;41:568-578. [PMID: 32305045 DOI: 10.1055/s-0040-1709160] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
23 Ohara H, Hung NV, Thu TA. Fact-finding survey of nosocomial infection control in hospitals in Vietnam and application to training programs. J Infect Chemother 2009;15:384-9. [PMID: 20012729 DOI: 10.1007/s10156-009-0718-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
24 Tomlinson B, Cockram C. SARS: experience at Prince of Wales Hospital, Hong Kong. Lancet. 2003;361:1486-1487. [PMID: 12737853 DOI: 10.1016/s0140-6736(03)13218-7] [Cited by in Crossref: 100] [Cited by in F6Publishing: 66] [Article Influence: 5.3] [Reference Citation Analysis]
25 Tan TT, Tan BH, Kurup A, Oon LL, Heng D, Thoe SY, Bai XL, Chan KP, Ling AE. Atypical SARS and Escherichia coli bacteremia. Emerg Infect Dis 2004;10:349-52. [PMID: 15030711 DOI: 10.3201/eid1002.030501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
26 Zhong X, Yang H, Guo ZF, Sin WY, Chen W, Xu J, Fu L, Wu J, Mak CK, Cheng CS, Yang Y, Cao S, Wong TY, Lai ST, Xie Y, Guo Z. B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein. J Virol 2005;79:3401-8. [PMID: 15731234 DOI: 10.1128/JVI.79.6.3401-3408.2005] [Cited by in Crossref: 69] [Cited by in F6Publishing: 52] [Article Influence: 4.1] [Reference Citation Analysis]
27 Johnston LB, Conly JM. Severe acute respiratory syndrome: What have we learned two years later? Can J Infect Dis Med Microbiol 2004;15:309-12. [PMID: 18159508 DOI: 10.1155/2004/964258] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
28 Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H. Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein. Biochem Biophys Res Commun 2004;319:746-52. [PMID: 15184046 DOI: 10.1016/j.bbrc.2004.05.046] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 3.9] [Reference Citation Analysis]
29 Lee YS, Chen CH, Chao A, Chen ES, Wei ML, Chen LK, Yang KD, Lin MC, Wang YH, Liu JW, Eng HL, Chiang PC, Wu TS, Tsao KC, Huang CG, Tien YJ, Wang TH, Wang HS, Lee YS. Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV). BMC Genomics 2005;6:132. [PMID: 16174304 DOI: 10.1186/1471-2164-6-132] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
30 Yount B, Curtis KM, Fritz EA, Hensley LE, Jahrling PB, Prentice E, Denison MR, Geisbert TW, Baric RS. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A 2003;100:12995-3000. [PMID: 14569023 DOI: 10.1073/pnas.1735582100] [Cited by in Crossref: 264] [Cited by in F6Publishing: 255] [Article Influence: 13.9] [Reference Citation Analysis]
31 Martinello RA, Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J Infect 2006;53:248-54. [PMID: 16412516 DOI: 10.1016/j.jinf.2005.11.010] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
32 Smales FC, Samaranyake LP. Maintaining dental education and specialist dental care during an outbreak of a new coronavirus infection. Part 1: a deadly viral epidemic begins. Br Dent J 2003;195:557-61. [PMID: 14631425 DOI: 10.1038/sj.bdj.4810723] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
33 Augustine R, S A, Nayeem A, Salam SA, Augustine P, Dan P, Maureira P, Mraiche F, Gentile C, Hansbro PM, McClements L, Hasan A. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation. Chem Biol Interact 2021;351:109738. [PMID: 34740598 DOI: 10.1016/j.cbi.2021.109738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
34 Lu L, Manopo I, Leung BP, Chng HH, Ling AE, Chee LL, Ooi EE, Chan SW, Kwang J. Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus. J Clin Microbiol 2004;42:1570-6. [PMID: 15071006 DOI: 10.1128/JCM.42.4.1570-1576.2004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
35 Ferrer M, Cosentini R, Nava S. The use of non-invasive ventilation during acute respiratory failure due to pneumonia. Eur J Intern Med 2012;23:420-8. [PMID: 22726370 DOI: 10.1016/j.ejim.2012.02.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
36 Wallinga J, Teunis P. Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. Am J Epidemiol 2004;160:509-16. [PMID: 15353409 DOI: 10.1093/aje/kwh255] [Cited by in Crossref: 786] [Cited by in F6Publishing: 569] [Article Influence: 43.7] [Reference Citation Analysis]
37 Goulia P, Mantas C, Dimitroula D, Mantis D, Hyphantis T. General hospital staff worries, perceived sufficiency of information and associated psychological distress during the A/H1N1 influenza pandemic. BMC Infect Dis. 2010;10:322. [PMID: 21062471 DOI: 10.1186/1471-2334-10-322] [Cited by in Crossref: 197] [Cited by in F6Publishing: 167] [Article Influence: 16.4] [Reference Citation Analysis]
38 Wong GW, Fok TF. Severe acute respiratory syndrome (SARS) in children. Pediatr Pulmonol Suppl 2004;26:69-71. [PMID: 15029602 DOI: 10.1002/ppul.70056] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
39 Ströher U, DiCaro A, Li Y, Strong JE, Aoki F, Plummer F, Jones SM, Feldmann H. Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha. J Infect Dis 2004;189:1164-7. [PMID: 15031783 DOI: 10.1086/382597] [Cited by in Crossref: 140] [Cited by in F6Publishing: 132] [Article Influence: 7.8] [Reference Citation Analysis]
40 Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004;203:631-7. [PMID: 15141377 DOI: 10.1002/path.1570] [Reference Citation Analysis]
41 Yu F, Le MQ, Inoue S, Thai HT, Hasebe F, Del Carmen Parquet M, Morita K. Evaluation of inapparent nosocomial severe acute respiratory syndrome coronavirus infection in Vietnam by use of highly specific recombinant truncated nucleocapsid protein-based enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 2005;12:848-54. [PMID: 16002634 DOI: 10.1128/CDLI.12.7.848-854.2005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
42 Ni L, Zhu J, Zhang J, Yan M, Gao GF, Tien P. Design of recombinant protein-based SARS-CoV entry inhibitors targeting the heptad-repeat regions of the spike protein S2 domain. Biochem Biophys Res Commun 2005;330:39-45. [PMID: 15781229 DOI: 10.1016/j.bbrc.2005.02.117] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
43 Woo PC, Lau SK, Tsoi HW, Chan KH, Wong BH, Che XY, Tam VK, Tam SC, Cheng VC, Hung IF, Wong SS, Zheng BJ, Guan Y, Yuen KY. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet 2004;363:841-5. [PMID: 15031027 DOI: 10.1016/S0140-6736(04)15729-2] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 5.7] [Reference Citation Analysis]
44 Nasiri M, Khodadadi J, Hajrezaei Z, Bizhani N. The Probable Association between Blood Groups and Prognosis of COVID-19. Iran J Public Health 2021;50:825-30. [PMID: 34183933 DOI: 10.18502/ijph.v50i4.6009] [Reference Citation Analysis]
45 Owolabi T, Kwolek S. Managing obstetrical patients during severe acute respiratory syndrome outbreak. J Obstet Gynaecol Can 2004;26:35-41. [PMID: 14715124 DOI: 10.1016/s1701-2163(16)30694-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
46 Cheng A, Zhang W, Xie Y, Jiang W, Arnold E, Sarafianos SG, Ding J. Expression, purification, and characterization of SARS coronavirus RNA polymerase. Virology 2005;335:165-76. [PMID: 15840516 DOI: 10.1016/j.virol.2005.02.017] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 4.6] [Reference Citation Analysis]
47 Petrosillo N, Puro V, Di Caro A, Ippolito G. The initial hospital response to an epidemic. Arch Med Res 2005;36:706-12. [PMID: 16216652 DOI: 10.1016/j.arcmed.2005.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
48 Yang ZY, Huang Y, Ganesh L, Leung K, Kong WP, Schwartz O, Subbarao K, Nabel GJ. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol 2004;78:5642-50. [PMID: 15140961 DOI: 10.1128/JVI.78.11.5642-5650.2004] [Cited by in Crossref: 338] [Cited by in F6Publishing: 263] [Article Influence: 18.8] [Reference Citation Analysis]
49 Muller MP, Dresser L, Raboud J, McGeer A, Rea E, Richardson SE, Mazzulli T, Loeb M, Louie M; Canadian SARS Research Network. Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome. Pharmacotherapy 2007;27:494-503. [PMID: 17381375 DOI: 10.1592/phco.27.4.494] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
50 Linani A, Benarous K, Bou-salah L, Yousfi M, Goumri-said S. Exploring Structural Mechanism of COVID-19 Treatment with Glutathione as a Potential Peptide Inhibitor to the Main Protease: Molecular Dynamics Simulation and MM/PBSA Free Energy Calculations Study. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10365-6] [Reference Citation Analysis]
51 Keightley MC, Sillekens P, Schippers W, Rinaldo C, George KS. Real-time NASBA detection of SARS-associated coronavirus and comparison with real-time reverse transcription-PCR. J Med Virol 2005;77:602-8. [PMID: 16254971 DOI: 10.1002/jmv.20498] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
52 Chen L, Liu P, Gao H, Sun B, Chao D, Wang F, Zhu Y, Hedenstierna G, Wang CG. Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing. Clin Infect Dis 2004;39:1531-5. [PMID: 15546092 DOI: 10.1086/425357] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 5.1] [Reference Citation Analysis]
53 Brun-Buisson C. SARS: the challenge of emerging pathogens to the intensivist. Intensive Care Med 2003;29:861-2. [PMID: 12858876 DOI: 10.1007/s00134-003-1823-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
54 Rochon PA, Mashari A, Cohen A, Misra A, Laxer D, Streiner DL, Dergal JM, Clark JP, Gold J, Binns MA. Relation between randomized controlled trials published in leading general medical journals and the global burden of disease. CMAJ 2004;170:1673-7. [PMID: 15159365 DOI: 10.1503/cmaj.1031006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
55 Abidi SH, Almansour NM, Amerzhanov D, Allemailem KS, Rafaqat W, Ibrahim MAA, la Fleur P, Lukac M, Ali S. Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase. Sci Rep 2021;11:10290. [PMID: 33986405 DOI: 10.1038/s41598-021-89724-0] [Reference Citation Analysis]
56 Ning Q, Yan WM, Wang ZM, Xi D, Liu MF, Levy G, Luo XP. Domain I of nucleocapsid protein of murine hepatitis virus strain 3 upregulates transcription of mfgl2 prothrimbinase/fibroleukin gene. Shijie Huaren Xiaohua Zazhi 2004; 12(3): 594-599 [DOI: 10.11569/wcjd.v12.i3.594] [Reference Citation Analysis]
57 Chen L, Li J, Luo C, Liu H, Xu W, Chen G, Liew OW, Zhu W, Puah CM, Shen X, Jiang H. Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure-activity relationship studies reveal salient pharmacophore features. Bioorg Med Chem 2006;14:8295-306. [PMID: 17046271 DOI: 10.1016/j.bmc.2006.09.014] [Cited by in F6Publishing: 120] [Reference Citation Analysis]
58 Chen HI. Acute lung injury and acute respiratory distress syndrome: experimental and clinical investigations. J Geriatr Cardiol 2011;8:44-54. [PMID: 22783284 DOI: 10.3724/SP.J.1263.2011.00044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 Chan JF, Li KS, To KK, Cheng VC, Chen H, Yuen KY. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J Infect 2012;65:477-89. [PMID: 23072791 DOI: 10.1016/j.jinf.2012.10.002] [Cited by in Crossref: 111] [Cited by in F6Publishing: 106] [Article Influence: 11.1] [Reference Citation Analysis]
60 Wu CY, Jan JT, Ma SH, Kuo CJ, Juan HF, Cheng YS, Hsu HH, Huang HC, Wu D, Brik A, Liang FS, Liu RS, Fang JM, Chen ST, Liang PH, Wong CH. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci U S A 2004;101:10012-7. [PMID: 15226499 DOI: 10.1073/pnas.0403596101] [Cited by in Crossref: 279] [Cited by in F6Publishing: 268] [Article Influence: 15.5] [Reference Citation Analysis]
61 Tanaka T, Kamitani W, DeDiego ML, Enjuanes L, Matsuura Y. Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA. J Virol 2012;86:11128-37. [PMID: 22855488 DOI: 10.1128/JVI.01700-12] [Cited by in Crossref: 119] [Cited by in F6Publishing: 84] [Article Influence: 11.9] [Reference Citation Analysis]
62 Vu HT, Leitmeyer KC, Le DH, Miller MJ, Nguyen QH, Uyeki TM, Reynolds MG, Aagesen J, Nicholson KG, Vu QH, Bach HA, Plan AJ. Clinical description of a completed outbreak of SARS in Vietnam, February-May 2003. Emerg Infect Dis 2004;10:334-8. [PMID: 15030707 DOI: 10.3201/eid1002.030761] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
63 Kuiken T, van den Hoogen BG, van Riel DA, Laman JD, van Amerongen G, Sprong L, Fouchier RA, Osterhaus AD. Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am J Pathol 2004;164:1893-900. [PMID: 15161626 DOI: 10.1016/S0002-9440(10)63750-9] [Cited by in Crossref: 111] [Cited by in F6Publishing: 48] [Article Influence: 6.2] [Reference Citation Analysis]
64 Leung TF, Wong GW, Hon KL, Fok TF. Severe acute respiratory syndrome (SARS) in children: epidemiology, presentation and management. Paediatr Respir Rev 2003;4:334-9. [PMID: 14629957 DOI: 10.1016/s1526-0542(03)00088-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
65 Ramakrishna S, Padhi S, Priyakumar UD. Modeling the structure of SARS 3a transmembrane protein using a minimum unfavorable contact approach. J Chem Sci (Bangalore) 2015;127:2159-69. [PMID: 32218650 DOI: 10.1007/s12039-015-0982-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
66 Mahmud-Al-Rafat A, Majumder A, Taufiqur Rahman KM, Mahedi Hasan AM, Didarul Islam KM, Taylor-Robinson AW, Billah MM. Decoding the enigma of antiviral crisis: Does one target molecule regulate all? Cytokine 2019;115:13-23. [PMID: 30616034 DOI: 10.1016/j.cyto.2018.12.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
67 Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436:112-116. [PMID: 16001071 DOI: 10.1038/nature03712] [Cited by in Crossref: 1473] [Cited by in F6Publishing: 1350] [Article Influence: 86.6] [Reference Citation Analysis]
68 Cui HJ, Tong XL, Li P, Hao YX, Chen XG, Li AG, Zhang ZY, Duan J, Zhen M, Zhang B, Hua CJ, Gong YW. Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: Retrospective analysis. World J Gastroenterol 2004; 10(11): 1652-1655 [PMID: 15162543 DOI: 10.3748/wjg.v10.i11.1652] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
69 Lowenstein R. Deadly viral syndrome mimics. Emerg Med Clin North Am 2004;22:1051-65, ix-x. [PMID: 15474781 DOI: 10.1016/j.emc.2004.05.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
70 Mukherjee P, Shah F, Desai P, Avery M. Inhibitors of SARS-3CLpro: virtual screening, biological evaluation, and molecular dynamics simulation studies. J Chem Inf Model 2011;51:1376-92. [PMID: 21604711 DOI: 10.1021/ci1004916] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
71 Chang HL, Chen KT, Lai SK, Kuo HW, Su IJ, Lin RS, Sung FC. Hematological and biochemical factors predicting SARS fatality in Taiwan. J Formos Med Assoc. 2006;105:439-450. [PMID: 16801031 DOI: 10.1016/s0929-6646(09)60183-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
72 Angelini MM, Akhlaghpour M, Neuman BW, Buchmeier MJ. Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles. mBio 2013;4:e00524-13. [PMID: 23943763 DOI: 10.1128/mBio.00524-13] [Cited by in Crossref: 201] [Cited by in F6Publishing: 161] [Article Influence: 22.3] [Reference Citation Analysis]
73 Ip WK, Chan KH, Law HK, Tso GH, Kong EK, Wong WH, To YF, Yung RW, Chow EY, Au KL, Chan EY, Lim W, Jensenius JC, Turner MW, Peiris JS, Lau YL. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005;191:1697-704. [PMID: 15838797 DOI: 10.1086/429631] [Cited by in Crossref: 165] [Cited by in F6Publishing: 157] [Article Influence: 9.7] [Reference Citation Analysis]
74 Yi L, Li Z, Yuan K, Qu X, Chen J, Wang G, Zhang H, Luo H, Zhu L, Jiang P, Chen L, Shen Y, Luo M, Zuo G, Hu J, Duan D, Nie Y, Shi X, Wang W, Han Y, Li T, Liu Y, Ding M, Deng H, Xu X. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J Virol 2004;78:11334-9. [PMID: 15452254 DOI: 10.1128/JVI.78.20.11334-11339.2004] [Cited by in Crossref: 181] [Cited by in F6Publishing: 127] [Article Influence: 10.1] [Reference Citation Analysis]
75 Chen YC, Huang LM, Chan CC, Su CP, Chang SC, Chang YY, Chen ML, Hung CC, Chen WJ, Lin FY, Lee YT; SARS Research Group of National Taiwan University College of Medicine and National Taiwan University Hospital. SARS in hospital emergency room. Emerg Infect Dis 2004;10:782-8. [PMID: 15200809 DOI: 10.3201/eid1005.030579] [Cited by in Crossref: 105] [Cited by in F6Publishing: 93] [Article Influence: 5.8] [Reference Citation Analysis]
76 Zhai J, Briese T, Dai E, Wang X, pang X, Du Z, Liu H, Wang J, Wang H, Guo Z, Chen Z, Jiang L, Zhou D, Han Y, Jabado O, Palacios G, Lipkin WI, Tang R. Real-time polymerase chain reaction for detecting SARS coronavirus, Beijing, 2003. Emerg Infect Dis 2004;10:300-3. [PMID: 15030701 DOI: 10.3201/eid1002.030799] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
77 Vicente D, Montes M, Cilla G, Pérez-Trallero E. Human metapneumovirus and chronic obstructive pulmonary disease. Emerg Infect Dis 2004;10:1338-9. [PMID: 15338546 DOI: 10.3201/eid1007.030633] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
78 Wang XW, Li JS, Guo TK, Zhen B, Kong QX, Yi B, Li Z, Song N, Jin M, Wu XM, Xiao WJ, Zhu XM, Gu CQ, Yin J, Wei W, Yao W, Liu C, Li JF, Ou GR, Wang MN, Fang TY, Wang GJ, Qiu YH, Wu HH, Chao FH, Li JW. Excretion and detection of SARS coronavirus and its nucleic acid from digestive system. World J Gastroenterol 2005; 11(28): 4390-4395 [PMID: 16038039 DOI: 10.3748/wjg.v11.i28.4390] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
79 Wohlford-Lenane CL, Meyerholz DK, Perlman S, Zhou H, Tran D, Selsted ME, McCray PB Jr. Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease. J Virol 2009;83:11385-90. [PMID: 19710146 DOI: 10.1128/JVI.01363-09] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 5.5] [Reference Citation Analysis]
80 Abdullah AS, Tomlinson B, Cockram CS, Thomas GN. Lessons from the severe acute respiratory syndrome outbreak in Hong Kong. Emerg Infect Dis 2003;9:1042-5. [PMID: 14519237 DOI: 10.3201/eid0909.030366] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
81 Jia HP, Look DC, Tan P, Shi L, Hickey M, Gakhar L, Chappell MC, Wohlford-Lenane C, McCray PB Jr. Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. Am J Physiol Lung Cell Mol Physiol 2009;297:L84-96. [PMID: 19411314 DOI: 10.1152/ajplung.00071.2009] [Cited by in Crossref: 184] [Cited by in F6Publishing: 176] [Article Influence: 14.2] [Reference Citation Analysis]
82 Meltzer MI. Multiple contact dates and SARS incubation periods. Emerg Infect Dis 2004;10:207-9. [PMID: 15030684 DOI: 10.3201/eid1002.030426] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
83 Yi WL, Fang F, Ning Q, Shu SN, Li G. Preventive and therapeutic effects of Shuanghuanglian and allitride against experimental murine hepatitis virus type 3 infection in vivoShijie Huaren Xiaohua Zazhi 2011; 19(22): 2316-2321 [DOI: 10.11569/wcjd.v19.i22.2316] [Reference Citation Analysis]
84 Ulloa-Gutierrez R. Metapneumovirus and its place in childhood. Paediatr Child Health 2003;8:613-5. [PMID: 20019852 DOI: 10.1093/pch/8.10.613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
85 Bhardwaj K, Guarino L, Kao CC. The severe acute respiratory syndrome coronavirus Nsp15 protein is an endoribonuclease that prefers manganese as a cofactor. J Virol. 2004;78:12218-12224. [PMID: 15507608 DOI: 10.1128/JVI.78.22.12218-12224.2004] [Cited by in Crossref: 135] [Cited by in F6Publishing: 102] [Article Influence: 7.5] [Reference Citation Analysis]
86 Chan PK, To KF, Lo AW, Cheung JL, Chu I, Au FW, Tong JH, Tam JS, Sung JJ, Ng HK. Persistent infection of SARS coronavirus in colonic cells in vitro. J Med Virol 2004;74:1-7. [PMID: 15258961 DOI: 10.1002/jmv.20138] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 3.4] [Reference Citation Analysis]
87 Chui L, Drebot M, Andonov A, Petrich A, Glushek M, Mahony J. Comparison of 9 different PCR primers for the rapid detection of severe acute respiratory syndrome coronavirus using 2 RNA extraction methods. Diagn Microbiol Infect Dis 2005;53:47-55. [PMID: 15994050 DOI: 10.1016/j.diagmicrobio.2005.03.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
88 Farquharson C, Baguley K. Responding to the Severe Acute Respiratory Syndrome (SARS) Outbreak: Lessons Learned in a Toronto Emergency Department. J Emerg Nurs 2020;46:742-7. [PMID: 33162020 DOI: 10.1016/j.jen.2020.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Hui DS, Sung JJ. Severe acute respiratory syndrome. Chest 2003;124:12-5. [PMID: 12853495 DOI: 10.1378/chest.124.1.12] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]
90 Li SY, Chen C, Zhang HQ, Guo HY, Wang H, Wang L, Zhang X, Hua SN, Yu J, Xiao PG, Li RS, Tan X. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res 2005;67:18-23. [PMID: 15885816 DOI: 10.1016/j.antiviral.2005.02.007] [Cited by in Crossref: 259] [Cited by in F6Publishing: 228] [Article Influence: 15.2] [Reference Citation Analysis]
91 Chen YC, Chang SC, Tsai KS, Lin FY. Certainties and uncertainties facing emerging respiratory infectious diseases: lessons from SARS. J Formos Med Assoc 2008;107:432-42. [PMID: 18583213 DOI: 10.1016/S0929-6646(08)60150-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
92 Cass D. Once upon a time in the emergency department: a cautionary tale. Ann Emerg Med 2005;46:541-3. [PMID: 16308071 DOI: 10.1016/j.annemergmed.2005.07.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
93 Dong J, Loeffelholz MJ, Mcginnis MR. Sequence‐Based Fungal Identification and Classification. In: Persing DH, Tenover FC, Tang Y, Nolle FS, Hayden RT, van Belkum A, editors. Molecular Microbiology. Wiley; 2011. pp. 669-76. [DOI: 10.1128/9781555816834.ch43] [Reference Citation Analysis]
94 Wang S, Sakhatskyy P, Chou TH, Lu S. Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV). J Immunol Methods 2005;301:21-30. [PMID: 15894326 DOI: 10.1016/j.jim.2005.03.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
95 Ngan Kee WD, Leung TN. Severe acute respiratory syndrome (SARS). Int J Obstet Anesth 2003;12:151-2. [PMID: 15321475 DOI: 10.1016/S0959-289X(03)00061-X] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
96 Lu HY, Xu XY, Lei Y, Wu YF, Chen BW, Xiao F, Xie GQ, Han DM. Clinical features of probable severe acute respiratory syndrome in Beijing. World J Gastroenterol 2005; 11(19): 2971-2974 [PMID: 15902739 DOI: 10.3748/wjg.v11.i19.2971] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
97 Wei WI, Ho WK. Severe acute respiratory syndrome: what have we learned. Adv Surg 2005;39:343-54. [PMID: 16250560 DOI: 10.1016/j.yasu.2005.04.001] [Reference Citation Analysis]
98 Oba Y. The use of corticosteroids in SARS. N Engl J Med 2003;348:2034-5; author reply 2034-5. [PMID: 12748321 DOI: 10.1056/NEJM200305153482017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
99 Peiris JS, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med 2004;10:S88-97. [PMID: 15577937 DOI: 10.1038/nm1143] [Cited by in Crossref: 636] [Cited by in F6Publishing: 564] [Article Influence: 37.4] [Reference Citation Analysis]
100 Phakthanakanok K, Ratanakhanokchai K, Kyu KL, Sompornpisut P, Watts A, Pinitglang S. A computational analysis of SARS cysteine proteinase-octapeptide substrate interaction: implication for structure and active site binding mechanism. BMC Bioinformatics 2009;10 Suppl 1:S48. [PMID: 19208150 DOI: 10.1186/1471-2105-10-S1-S48] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
101 Tsao YP, Lin JY, Jan JT, Leng CH, Chu CC, Yang YC, Chen SL. HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins. Biochem Biophys Res Commun 2006;344:63-71. [PMID: 16630549 DOI: 10.1016/j.bbrc.2006.03.152] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
102 Bukreyev A, Lamirande EW, Buchholz UJ, Vogel LN, Elkins WR, St Claire M, Murphy BR, Subbarao K, Collins PL. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet 2004;363:2122-7. [PMID: 15220033 DOI: 10.1016/S0140-6736(04)16501-X] [Cited by in Crossref: 183] [Cited by in F6Publishing: 141] [Article Influence: 10.2] [Reference Citation Analysis]
103 Chen HI, Kao SJ, Wang D, Lee RP, Su CF. Acute respiratory distress syndrome. J Biomed Sci 2003;10:588-92. [PMID: 14576460 DOI: 10.1159/000073523] [Cited by in Crossref: 36] [Article Influence: 2.0] [Reference Citation Analysis]
104 Feng D, de Vlas SJ, Fang LQ, Han XN, Zhao WJ, Sheng S, Yang H, Jia ZW, Richardus JH, Cao WC. The SARS epidemic in mainland China: bringing together all epidemiological data. Trop Med Int Health 2009;14 Suppl 1:4-13. [PMID: 19508441 DOI: 10.1111/j.1365-3156.2008.02145.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
105 Tambyah PA. SARS: responding to an unknown virus. Eur J Clin Microbiol Infect Dis 2004;23:589-95. [PMID: 15252720 DOI: 10.1007/s10096-004-1175-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
106 Sampath R, Hall TA, Massire C, Li F, Blyn LB, Eshoo MW, Hofstadler SA, Ecker DJ. Rapid identification of emerging infectious agents using PCR and electrospray ionization mass spectrometry. Ann N Y Acad Sci 2007;1102:109-20. [PMID: 17470915 DOI: 10.1196/annals.1408.008] [Cited by in Crossref: 81] [Cited by in F6Publishing: 69] [Article Influence: 5.4] [Reference Citation Analysis]
107 Verbeek PR, McClelland IW, Silverman AC, Burgess RJ. Loss of paramedic availability in an urban emergency medical services system during a severe acute respiratory syndrome outbreak. Acad Emerg Med 2004;11:973-8. [PMID: 15347550 DOI: 10.1197/j.aem.2004.03.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
108 Chan PK, Chan MC. Tracing the SARS-coronavirus. J Thorac Dis 2013;5 Suppl 2:S118-21. [PMID: 23977431 DOI: 10.3978/j.issn.2072-1439.2013.06.19] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
109 Sundaram M, Ravikumar N, Bansal A, Nallasamy K, Basavaraja GV, Lodha R, Gupta D, Odena MP, Ashwath RNR, Jayashree M; Intensive Care Chapter of Indian Academy of Pediatrics. Novel Coronavirus 2019 (2019-nCoV) Infection: Part II - Respiratory Support in the Pediatric Intensive Care Unit in Resource-limited Settings. Indian Pediatr 2020;57:335-42. [PMID: 32238613 [PMID: 32238613 DOI: 10.1007/s13312-020-1786-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 6.5] [Reference Citation Analysis]
110 Navas-Martín SR, Weiss S. Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development. J Neurovirol 2004;10:75-85. [PMID: 15204926 DOI: 10.1080/13550280490280292] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
111 Dong J, Olano JP, McBride JW, Walker DH. Emerging pathogens: challenges and successes of molecular diagnostics. J Mol Diagn 2008;10:185-97. [PMID: 18403608 DOI: 10.2353/jmoldx.2008.070063] [Cited by in Crossref: 82] [Cited by in F6Publishing: 69] [Article Influence: 5.9] [Reference Citation Analysis]
112 Maunder R. The experience of the 2003 SARS outbreak as a traumatic stress among frontline healthcare workers in Toronto: lessons learned. Philos Trans R Soc Lond B Biol Sci 2004;359:1117-25. [PMID: 15306398 DOI: 10.1098/rstb.2004.1483] [Cited by in Crossref: 164] [Cited by in F6Publishing: 149] [Article Influence: 9.1] [Reference Citation Analysis]
113 Foulongne V, Lechiche C, Reynes J, Segondy M. [Human metapneumovirus pneumonia in an adult patient hospitalized for suspected severe acute respiratory syndrome (SARS)]. Presse Med 2004;33:1006-7. [PMID: 15523245 DOI: 10.1016/s0755-4982(04)98824-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
114 Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, Alabdullatif ZN, Assad M, Almulhim A, Makhdoom H, Madani H, Alhakeem R, Al-Tawfiq JA, Cotten M, Watson SJ, Kellam P, Zumla AI, Memish ZA;  KSA MERS-CoV Investigation Team. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013;369:407-416. [PMID: 23782161 DOI: 10.1056/nejmoa1306742] [Cited by in Crossref: 782] [Cited by in F6Publishing: 610] [Article Influence: 86.9] [Reference Citation Analysis]
115 Gerna G, Campanini G, Rovida F, Percivalle E, Sarasini A, Marchi A, Baldanti F. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. J Med Virol 2006;78:938-49. [PMID: 16721849 DOI: 10.1002/jmv.20645] [Cited by in Crossref: 110] [Cited by in F6Publishing: 98] [Article Influence: 6.9] [Reference Citation Analysis]
116 Kaddoura M, AlIbrahim M, Hijazi G, Soudani N, Audi A, Alkalamouni H, Haddad S, Eid A, Zaraket H. COVID-19 Therapeutic Options Under Investigation. Front Pharmacol 2020;11:1196. [PMID: 32848795 DOI: 10.3389/fphar.2020.01196] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
117 Chen Z, Lv Y, Xu H, Deng L. Herbal Medicine, Gut Microbiota, and COVID-19. Front Pharmacol 2021;12:646560. [PMID: 34305582 DOI: 10.3389/fphar.2021.646560] [Reference Citation Analysis]
118 Wang WK, Chen SY, Liu IJ, Chen YC, Chen HL, Yang CF, Chen PJ, Yeh SH, Kao CL, Huang LM, Hsueh PR, Wang JT, Sheng WH, Fang CT, Hung CC, Hsieh SM, Su CP, Chiang WC, Yang JY, Lin JH, Hsieh SC, Hu HP, Chiang YP, Wang JT, Yang PC, Chang SC; SARS Research Group of the National Taiwan University/National Taiwan University Hospital. Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis 2004;10:1213-9. [PMID: 15324540 DOI: 10.3201/eid1007.031113] [Cited by in Crossref: 132] [Cited by in F6Publishing: 116] [Article Influence: 7.3] [Reference Citation Analysis]
119 He R, Leeson A, Andonov A, Li Y, Bastien N, Cao J, Osiowy C, Dobie F, Cutts T, Ballantine M, Li X. Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein. Biochem Biophys Res Commun 2003;311:870-6. [PMID: 14623261 DOI: 10.1016/j.bbrc.2003.10.075] [Cited by in Crossref: 86] [Cited by in F6Publishing: 87] [Article Influence: 4.8] [Reference Citation Analysis]
120 Loon SC, Teoh SC, Oon LL, Se-Thoe SY, Ling AE, Leo YS, Leong HN. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol 2004;88:861-3. [PMID: 15205225 DOI: 10.1136/bjo.2003.035931] [Cited by in Crossref: 162] [Cited by in F6Publishing: 135] [Article Influence: 9.0] [Reference Citation Analysis]
121 Robertson E, Hershenfield K, Grace SL, Stewart DE. The Psychosocial Effects of Being Quarantined following Exposure to SARS: A Qualitative Study of Toronto Health Care Workers. Can J Psychiatry 2004;49:403-7. [DOI: 10.1177/070674370404900612] [Cited by in Crossref: 152] [Cited by in F6Publishing: 112] [Article Influence: 8.4] [Reference Citation Analysis]
122 Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, Chu CM, Hui PK, Mak KL, Lim W, Yan KW, Chan KH, Tsang NC, Guan Y, Yuen KY, Peiris JS. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003;361:1773-1778. [PMID: 12781536 DOI: 10.1016/s0140-6736(03)13413-7] [Cited by in Crossref: 687] [Cited by in F6Publishing: 522] [Article Influence: 36.2] [Reference Citation Analysis]
123 Poon LLM, Chan KH, Nicholls JM, Zheng BJ, Yuen KY, Guan Y, Peiris JSM. Characterization of a novel coronavirus responsible for severe acute respiratory syndrome. Int Congr Ser 2004;1263:805-8. [PMID: 32288144 DOI: 10.1016/j.ics.2004.02.105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
124 Wu D, Tu C, Xin C, Xuan H, Meng Q, Liu Y, Yu Y, Guan Y, Jiang Y, Yin X, Crameri G, Wang M, Li C, Liu S, Liao M, Feng L, Xiang H, Sun J, Chen J, Sun Y, Gu S, Liu N, Fu D, Eaton BT, Wang LF, Kong X. Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates. J Virol 2005;79:2620-5. [PMID: 15681462 DOI: 10.1128/JVI.79.4.2620-2625.2005] [Cited by in Crossref: 84] [Cited by in F6Publishing: 62] [Article Influence: 4.9] [Reference Citation Analysis]
125 Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect Dis. 2003;3:722-727. [PMID: 14592603 DOI: 10.1016/s1473-3099(03)00806-5] [Cited by in Crossref: 702] [Cited by in F6Publishing: 459] [Article Influence: 36.9] [Reference Citation Analysis]
126 Jernigan JA, Low DE, Hefland RF. Combining clinical and epidemiologic features for early recognition of SARS. Emerg Infect Dis 2004;10:327-33. [PMID: 15030706 DOI: 10.3201/eid1002.030741] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
127 Vicenzi E, Canducci F, Pinna D, Mancini N, Carletti S, Lazzarin A, Bordignon C, Poli G, Clementi M. Coronaviridae and SARS-associated coronavirus strain HSR1. Emerg Infect Dis 2004;10:413-8. [PMID: 15109406 DOI: 10.3201/eid1003.030683] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 4.6] [Reference Citation Analysis]
128 Farrugia A, Cassar J. Is self-sufficiency in haemotherapies a practical or necessary goal? Blood Transfus 2013;11:183-92. [PMID: 23245724 DOI: 10.2450/2012.0148-12] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
129 Loeb M, McGeer A, Henry B, Ofner M, Rose D, Hlywka T, Levie J, McQueen J, Smith S, Moss L, Smith A, Green K, Walter SD. SARS among critical care nurses, Toronto. Emerg Infect Dis 2004;10:251-5. [PMID: 15030692 DOI: 10.3201/eid1002.030838] [Cited by in Crossref: 202] [Cited by in F6Publishing: 193] [Article Influence: 11.2] [Reference Citation Analysis]
130 Chan PK, To KF, Wu A, Tse GM, Chan KF, Lui SF, Sung JJ, Tam JS, Tomlinson B. Human metapneumovirus-associated atypical pneumonia and SARS. Emerg Infect Dis 2004;10:497-500. [PMID: 15109421 DOI: 10.3201/eid1003.030513] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
131 Krokhin O, Li Y, Andonov A, Feldmann H, Flick R, Jones S, Stroeher U, Bastien N, Dasuri KV, Cheng K, Simonsen JN, Perreault H, Wilkins J, Ens W, Plummer F, Standing KG. Mass spectrometric characterization of proteins from the SARS virus: a preliminary report. Mol Cell Proteomics 2003;2:346-56. [PMID: 12775768 DOI: 10.1074/mcp.M300048-MCP200] [Cited by in Crossref: 114] [Cited by in F6Publishing: 88] [Article Influence: 6.0] [Reference Citation Analysis]
132 De Groot AS. How the SARS vaccine effort can learn from HIV-speeding towards the future, learning from the past. Vaccine 2003;21:4095-104. [PMID: 14505885 DOI: 10.1016/s0264-410x(03)00489-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
133 Wilder-Smith A, Paton NI, Goh KT. Experience of severe acute respiratory syndrome in singapore: importation of cases, and defense strategies at the airport. J Travel Med 2003;10:259-62. [PMID: 14531977 DOI: 10.2310/7060.2003.2676] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
134 Tsai MH, Lin TY, Chiu CH, Lin PY, Huang YC, Tsao KC, Huang CG, Hsu KH, Lin MC, Hwang KP, Yang KD. Seroprevalence of SARS Coronavirus Among Residents Near a Hospital with a Nosocomial Outbreak. J Formos Med Assoc 2008;107:885-91. [PMID: 18971158 DOI: 10.1016/S0929-6646(08)60205-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
135 Tsai MC, Arnold JL, Chuang CC, Chi CH, Liu CC, Yang YJ. Implementation of the Hospital Emergency Incident Command System during an outbreak of severe acute respiratory syndrome (SARS) at a hospital in Taiwan, ROC. J Emerg Med 2005;28:185-96. [PMID: 15707815 DOI: 10.1016/j.jemermed.2004.04.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
136 Yoo HM, Kim IH, Kim S. Nucleic Acid Testing of SARS-CoV-2. Int J Mol Sci 2021;22:6150. [PMID: 34200331 DOI: 10.3390/ijms22116150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Hsueh PR, Huang LM, Chen PJ, Kao CL, Yang PC. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin Microbiol Infect 2004;10:1062-6. [PMID: 15606632 DOI: 10.1111/j.1469-0691.2004.01009.x] [Cited by in Crossref: 160] [Cited by in F6Publishing: 143] [Article Influence: 9.4] [Reference Citation Analysis]
138 van Elden LJ, van Loon AM, van Alphen F, Hendriksen KA, Hoepelman AI, van Kraaij MG, Oosterheert JJ, Schipper P, Schuurman R, Nijhuis M. Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction. J Infect Dis 2004;189:652-7. [PMID: 14767819 DOI: 10.1086/381207] [Cited by in Crossref: 139] [Cited by in F6Publishing: 129] [Article Influence: 7.7] [Reference Citation Analysis]
139 Flamaing J, Engelmann I, Joosten E, Van Ranst M, Verhaegen J, Peetermans WE. Viral lower respiratory tract infection in the elderly: a prospective in-hospital study. Eur J Clin Microbiol Infect Dis 2003;22:720-5. [PMID: 14605944 DOI: 10.1007/s10096-003-1042-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
140 Lu HY, Xu XY, Lei Y, Wu YF, Chen BW, Xiao F, Xie GQ, Han DM. Characteristics of 1 062 patients with SARS in early stage in Beijing. Shijie Huaren Xiaohua Zazhi 2004; 12(5): 1149-1154 [DOI: 10.11569/wcjd.v12.i5.1149] [Reference Citation Analysis]
141 Galvani AP, Lei X, Jewell NP. Severe acute respiratory syndrome: temporal stability and geographic variation in case-fatality rates and doubling times. Emerg Infect Dis 2003;9:991-4. [PMID: 12967499 DOI: 10.3201/eid0908.030334] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
142 Tomizuka T, Kanatani Y, Kawahara K. Insufficient preparedness of primary care practices for pandemic influenza and the effect of a preparedness plan in Japan: a prefecture-wide cross-sectional study. BMC Fam Pract 2013;14:174. [PMID: 24252688 DOI: 10.1186/1471-2296-14-174] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
143 Wong GW, Li AM, Ng PC, Fok TF. Severe acute respiratory syndrome in children. Pediatr Pulmonol 2003;36:261-6. [PMID: 12950037 DOI: 10.1002/ppul.10367] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
144 Han X, Bartlam M, Jin YH, Liu X, He X, Cai X, Xie Q, Rao Z. The expression of SARS-CoV M gene in P. Pastoris and the diagnostic utility of the expression product. J Virol Methods 2004;122:105-11. [PMID: 15488627 DOI: 10.1016/j.jviromet.2004.08.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
145 Herold CJ, Sailer JG. Community-acquired and nosocomial pneumonia. Eur Radiol. 2004;14 Suppl 3:E2-20. [PMID: 14749949 DOI: 10.1007/s00330-003-2162-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
146 Gomes da Silva J, Silva CS, Alexandre B, Morgado P. Education as a Predictor Factor for Knowledge of COVID-19 in Portugal. Front Public Health 2021;9:680726. [PMID: 34660506 DOI: 10.3389/fpubh.2021.680726] [Reference Citation Analysis]
147 Bossi P, Guihot A, Ansart S, Bricaire F. [Severe acute respiratory syndrome: update]. Rev Med Interne 2003;24:672-80. [PMID: 14550520 DOI: 10.1016/s0248-8663(03)00262-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
148 Sun J, Deng X, Chen X, Huang J, Huang S, Li Y, Feng J, Liu J, He G. Incidence of Adverse Drug Reactions in COVID-19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System. Clin Pharmacol Ther. 2020;108:791-797. [PMID: 32324898 DOI: 10.1002/cpt.1866] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
149 Sampathkumar P, Temesgen Z, Smith TF, Thompson RL. SARS: epidemiology, clinical presentation, management, and infection control measures. Mayo Clin Proc 2003;78:882-90. [PMID: 12839084 DOI: 10.4065/78.7.882] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
150 Wong CKH, Wong JYH, Tang EHM, Au CH, Wai AKC. Clinical presentations, laboratory and radiological findings, and treatments for 11,028 COVID-19 patients: a systematic review and meta-analysis. Sci Rep 2020;10:19765. [PMID: 33188232 DOI: 10.1038/s41598-020-74988-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
151 Li RW, Leung KW, Sun FC, Samaranayake LP. Severe Acute Respiratory Syndrome (SARS) and the GDP. Part I : Epidemiology, virology, pathology and general health issues. Br Dent J 2004;197:77-80. [PMID: 15272339 DOI: 10.1038/sj.bdj.4811469] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
152 Wong E, Ho KK. The effect of severe acute respiratory syndrome (SARS) on emergency airway management. Resuscitation 2006;70:26-30. [PMID: 16762480 DOI: 10.1016/j.resuscitation.2005.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
153 McBryde ES, Gibson G, Pettitt AN, Zhang Y, Zhao B, McElwain DL. Bayesian modelling of an epidemic of severe acute respiratory syndrome. Bull Math Biol 2006;68:889-917. [PMID: 16802088 DOI: 10.1007/s11538-005-9005-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
154 Shih MC, Peck K, Chan WL, Chu YP, Chen JC, Tsai CH, Chang JG. SARS-CoV infection was from at least two origins in the Taiwan area. Intervirology 2005;48:124-32. [PMID: 15812185 DOI: 10.1159/000081739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
155 Lin CW, Lin KH, Hsieh TH, Shiu SY, Li JY. Severe acute respiratory syndrome coronavirus 3C-like protease-induced apoptosis. FEMS Immunol Med Microbiol 2006;46:375-80. [PMID: 16553810 DOI: 10.1111/j.1574-695X.2006.00045.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 4.1] [Reference Citation Analysis]
156 Zhao GP. SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era. Philos Trans R Soc Lond B Biol Sci 2007;362:1063-81. [PMID: 17327210 DOI: 10.1098/rstb.2007.2034] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
157 Meadows E, Le Saux N. A systematic review of the effectiveness of antimicrobial rinse-free hand sanitizers for prevention of illness-related absenteeism in elementary school children. BMC Public Health 2004;4:50. [PMID: 15518593 DOI: 10.1186/1471-2458-4-50] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
158 Shen Z, Ning F, Zhou W, He X, Lin C, Chin DP, Zhu Z, Schuchat A. Superspreading SARS events, Beijing, 2003. Emerg Infect Dis 2004;10:256-60. [PMID: 15030693 DOI: 10.3201/eid1002.030732] [Cited by in Crossref: 175] [Cited by in F6Publishing: 142] [Article Influence: 9.7] [Reference Citation Analysis]
159 Twu SJ, Chen TJ, Chen CJ, Olsen SJ, Lee LT, Fisk T, Hsu KH, Chang SC, Chen KT, Chiang IH, Wu YC, Wu JS, Dowell SF. Control measures for severe acute respiratory syndrome (SARS) in Taiwan. Emerg Infect Dis 2003;9:718-20. [PMID: 12781013 DOI: 10.3201/eid0906.030283] [Cited by in Crossref: 109] [Cited by in F6Publishing: 107] [Article Influence: 5.7] [Reference Citation Analysis]
160 McCarthy AE. Tropical travel and life-threatening disease: preventing malaria misadventures. Can J Infect Dis 2003;14:143-4. [PMID: 18159445 DOI: 10.1155/2003/865054] [Reference Citation Analysis]
161 Bosch BJ, van der Zee R, de Haan CA, Rottier PJ. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 2003;77:8801-11. [PMID: 12885899 DOI: 10.1128/jvi.77.16.8801-8811.2003] [Cited by in Crossref: 777] [Cited by in F6Publishing: 578] [Article Influence: 40.9] [Reference Citation Analysis]
162 St John RK, King A, de Jong D, Bodie-Collins M, Squires SG, Tam TW. Border screening for SARS. Emerg Infect Dis 2005;11:6-10. [PMID: 15705315 DOI: 10.3201/eid1101.040835] [Cited by in Crossref: 80] [Cited by in F6Publishing: 66] [Article Influence: 4.7] [Reference Citation Analysis]
163 Marsden PA, Ning Q, Fung LS, Luo X, Chen Y, Mendicino M, Ghanekar A, Scott JA, Miller T, Chan CW. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest. 2003;112:58-66. [PMID: 12840059 DOI: 10.1172/jci18114] [Cited by in Crossref: 114] [Cited by in F6Publishing: 78] [Article Influence: 6.0] [Reference Citation Analysis]
164 Demmler GJ, Ligon BL. Severe acute respiratory syndrome (SARS): a review of the history, epidemiology, prevention, and concerns for the future. Semin Pediatr Infect Dis 2003;14:240-4. [PMID: 12913837 DOI: 10.1016/s1045-1870(03)00056-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
165 Maxwell C, McGeer A, Tai KFY, Sermer M. No. 225-Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS). J Obstet Gynaecol Can. 2017;39:e130-e137. [PMID: 28729104 DOI: 10.1016/j.jogc.2017.04.024] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 16.3] [Reference Citation Analysis]
166 Timen A, van Doornum GJ, Schutten M, Conyn-van Spaendonck MA, van der Meer JW, Osterhaus AD, van Steenbergen JE. Public health implications of using various case definitions in The Netherlands during the worldwide SARS outbreak. Clin Microbiol Infect 2006;12:1214-20. [PMID: 17121628 DOI: 10.1111/j.1469-0691.2006.01552.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
167 Woo PC, Lau SK, Wong BH, Tsoi HW, Fung AM, Chan KH, Tam VK, Peiris JS, Yuen KY. Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol 2004;42:2306-9. [PMID: 15131220 DOI: 10.1128/JCM.42.5.2306-2309.2004] [Cited by in Crossref: 87] [Cited by in F6Publishing: 69] [Article Influence: 4.8] [Reference Citation Analysis]
168 Zahariadis G, Gooley TA, Ryall P, Hutchinson C, Latchford MI, Fearon MA, Jamieson FB, Richardson S, Kuschak T, Mederski B. Risk of ruling out severe acute respiratory syndrome by ruling in another diagnosis: variable incidence of atypical bacteria coinfection based on diagnostic assays. Can Respir J 2006;13:17-22. [PMID: 16470249 DOI: 10.1155/2006/862797] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
169 Fulford M, Keystone JS. Health Risks Associated with Visiting Friends and Relatives in Developing Countries. Curr Infect Dis Rep 2005;7:48-53. [PMID: 15610671 DOI: 10.1007/s11908-005-0023-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
170 Vlantis AC, Tsang RK, Wong DK, Woo JK, van Hasselt CA. The impact of severe acute respiratory syndrome on otorhinolaryngological services at the Prince of Wales Hospital in Hong Kong. Laryngoscope 2004;114:171-4. [PMID: 14710016 DOI: 10.1097/00005537-200401000-00032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
171 Paar M, Strumann C, Giesen H. Rate and predictive parameters of novel Coronavirus 2019 (Sars-CoV-2) infections in a German General Practice. Ir J Med Sci 2021. [PMID: 33594623 DOI: 10.1007/s11845-021-02555-w] [Reference Citation Analysis]
172 Subbarao K, McAuliffe J, Vogel L, Fahle G, Fischer S, Tatti K, Packard M, Shieh WJ, Zaki S, Murphy B. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol 2004;78:3572-7. [PMID: 15016880 DOI: 10.1128/jvi.78.7.3572-3577.2004] [Cited by in Crossref: 307] [Cited by in F6Publishing: 244] [Article Influence: 17.1] [Reference Citation Analysis]
173 Mirzaei A, Moghim S. SARS-CoV-2, SARS and MERS: Three formidable coronaviruses which have originated from bats. Postepy Hig Med Dosw 2021;75:91-100. [DOI: 10.5604/01.3001.0014.7476] [Reference Citation Analysis]
174 Han DP, Lohani M, Cho MW. Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry. J Virol 2007;81:12029-39. [PMID: 17715238 DOI: 10.1128/JVI.00315-07] [Cited by in Crossref: 87] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
175 Cornillez-Ty CT, Liao L, Yates JR 3rd, Kuhn P, Buchmeier MJ. Severe acute respiratory syndrome coronavirus nonstructural protein 2 interacts with a host protein complex involved in mitochondrial biogenesis and intracellular signaling. J Virol 2009;83:10314-8. [PMID: 19640993 DOI: 10.1128/JVI.00842-09] [Cited by in Crossref: 108] [Cited by in F6Publishing: 78] [Article Influence: 8.3] [Reference Citation Analysis]
176 Jones BM, Ma ES, Peiris JS, Wong PC, Ho JC, Lam B, Lai KN, Tsang KW. Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids. Clin Exp Immunol. 2004;135:467-473. [PMID: 15008980 DOI: 10.1111/j.1365-2249.2003.02391.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
177 Al-Tawfiq JA, Zumla A, Memish ZA. Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med Infect Dis 2014;12:422-8. [PMID: 25047726 DOI: 10.1016/j.tmaid.2014.06.007] [Cited by in Crossref: 95] [Cited by in F6Publishing: 67] [Article Influence: 11.9] [Reference Citation Analysis]
178 Liu X, Shi Y, Li P, Li L, Yi Y, Ma Q, Cao C. Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients. Clin Diagn Lab Immunol 2004;11:227-8. [PMID: 14715574 DOI: 10.1128/cdli.11.1.227-228.2004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
179 Pormohammad A, Ghorbani S, Khatami A, Farzi R, Baradaran B, Turner DL, Turner RJ, Bahr NC, Idrovo JP. Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis. Rev Med Virol. 2020;30:e2112. [PMID: 32502331 DOI: 10.1002/rmv.2112] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
180 Kariyawasam JC, Jayarajah U, Riza R, Abeysuriya V, Seneviratne SL. Gastrointestinal manifestations in COVID-19. Trans R Soc Trop Med Hyg 2021:trab042. [PMID: 33728439 DOI: 10.1093/trstmh/trab042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
181 File TM Jr, Tsang KW. Severe acute respiratory syndrome: pertinent clinical characteristics and therapy. Treat Respir Med 2005;4:95-106. [PMID: 15813661 DOI: 10.2165/00151829-200504020-00003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
182 Adedeji AO, Singh K, Kassim A, Coleman CM, Elliott R, Weiss SR, Frieman MB, Sarafianos SG. Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses. Antimicrob Agents Chemother 2014;58:4894-8. [PMID: 24841268 DOI: 10.1128/AAC.02994-14] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 7.9] [Reference Citation Analysis]
183 Diaz JV, Riviello ED, Papali A, Adhikari NKJ, Ferreira JC. Global Critical Care: Moving Forward in Resource-Limited Settings. Ann Glob Health 2019;85:3. [PMID: 30741504 DOI: 10.5334/aogh.2413] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
184 Lan YC, Liu HF, Shih YP, Yang JY, Chen HY, Chen YM. Phylogenetic analysis and sequence comparisons of structural and non-structural SARS coronavirus proteins in Taiwan. Infect Genet Evol 2005;5:261-9. [PMID: 15737918 DOI: 10.1016/j.meegid.2004.08.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
185 Li AM, Ng PC. Severe acute respiratory syndrome (SARS) in neonates and children. Arch Dis Child Fetal Neonatal Ed 2005;90:F461-5. [PMID: 16244207 DOI: 10.1136/adc.2005.075309] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 4.1] [Reference Citation Analysis]
186 Ewig S. [SARS. A lesson in infection epidemiology and a masterpiece of modern infection control]. Pathologe 2003;24:335-7. [PMID: 12961021 DOI: 10.1007/s00292-003-0637-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
187 Kuba K, Imai Y, Rao S, Jiang C, Penninger JM. Lessons from SARS: control of acute lung failure by the SARS receptor ACE2. J Mol Med (Berl) 2006;84:814-20. [PMID: 16988814 DOI: 10.1007/s00109-006-0094-9] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]
188 Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, Yeung YC, Choi KW, Tso YK, Lau T, Lai ST, Lai CL. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology 2004;39:302-10. [PMID: 14767982 DOI: 10.1002/hep.20111] [Reference Citation Analysis]
189 He Z, Dong Q, Zhuang H, Song S, Peng G, Luo G, Dwyer DE. Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS. Clin Diagn Lab Immunol 2004;11:792-4. [PMID: 15242960 DOI: 10.1128/CDLI.11.4.792-794.2004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
190 Chen CY, Lee CH, Liu CY, Wang JH, Wang LM, Perng RP. Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome. J Chin Med Assoc. 2005;68:4-10. [PMID: 15742856 DOI: 10.1016/s1726-4901(09)70124-8] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
191 Nicholls J, Dong XP, Jiang G, Peiris M. SARS: clinical virology and pathogenesis. Respirology 2003;8 Suppl:S6-8. [PMID: 15018126 DOI: 10.1046/j.1440-1843.2003.00517.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 3.0] [Reference Citation Analysis]
192 Ram S. Coronavirus Research Trends: A 50–Year Bibliometric Assessment. Science & Technology Libraries 2020;39:210-26. [DOI: 10.1080/0194262x.2020.1742270] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 8.5] [Reference Citation Analysis]
193 Chen HI, Kao SJ, Wang D, Lee RP, Su CF. Acute respiratory distress syndrome. J Biomed Sci. 2003;10:588-592. [PMID: 14576460 DOI: 10.1159/000073523] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.1] [Reference Citation Analysis]
194 Sarasini A, Percivalle E, Rovida F, Campanini G, Genini E, Torsellini M, Paolucci S, Baldanti F, Marchi A, Grazia Revello M, Gerna G. Detection and pathogenicity of human metapneumovirus respiratory infection in pediatric Italian patients during a winter--spring season. J Clin Virol 2006;35:59-68. [PMID: 16023411 DOI: 10.1016/j.jcv.2005.05.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
195 Yuan X, Wu J, Shan Y, Yao Z, Dong B, Chen B, Zhao Z, Wang S, Chen J, Cong Y. SARS coronavirus 7a protein blocks cell cycle progression at G0/G1 phase via the cyclin D3/pRb pathway. Virology 2006;346:74-85. [PMID: 16303160 DOI: 10.1016/j.virol.2005.10.015] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 5.1] [Reference Citation Analysis]
196 Mudgal R, Nehul S, Tomar S. Prospects for mucosal vaccine: shutting the door on SARS-CoV-2. Hum Vaccin Immunother 2020;16:2921-31. [PMID: 32931361 DOI: 10.1080/21645515.2020.1805992] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
197 Quach C, McArthur M, McGeer A, Li L, Simor A, Dionne M, Lévesque E, Tremblay L. Risk of infection following a visit to the emergency department: a cohort study. CMAJ 2012;184:E232-9. [PMID: 22271915 DOI: 10.1503/cmaj.110372] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
198 Risku M, Lappalainen S, Räsänen S, Vesikari T. Detection of human coronaviruses in children with acute gastroenteritis. J Clin Virol 2010;48:27-30. [PMID: 20233673 DOI: 10.1016/j.jcv.2010.02.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
199 Sutton TC, Subbarao K. Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus. Virology 2015;479-480:247-58. [PMID: 25791336 DOI: 10.1016/j.virol.2015.02.030] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 8.1] [Reference Citation Analysis]
200 Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, Yeung YC, Choi KW, Tso YK, Lau T, Lai ST, Lai CL. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology 2004;39:302-10. [PMID: 14767982 DOI: 10.1002/hep.20111] [Cited by in Crossref: 261] [Cited by in F6Publishing: 232] [Article Influence: 14.5] [Reference Citation Analysis]
201 Saif LJ, Jung K. Comparative Pathogenesis of Bovine and Porcine Respiratory Coronaviruses in the Animal Host Species and SARS-CoV-2 in Humans. J Clin Microbiol 2020;58:e01355-20. [PMID: 32522830 DOI: 10.1128/JCM.01355-20] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
202 Danesh F, Dastani M, Ghorbani M. Retrospective and prospective approaches of coronavirus publications in the last half-century: a Latent Dirichlet allocation analysis. LHT 2021;39:855-72. [DOI: 10.1108/lht-09-2020-0216] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
203 Oh MD, Choe PG, Oh HS, Park WB, Lee SM, Park J, Lee SK, Song JS, Kim NJ. Middle East Respiratory Syndrome Coronavirus Superspreading Event Involving 81 Persons, Korea 2015. J Korean Med Sci 2015;30:1701-5. [PMID: 26539018 DOI: 10.3346/jkms.2015.30.11.1701] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 7.6] [Reference Citation Analysis]
204 Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ, Ng WL, Lai RW, Guan Y, Yuen KY;  HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767-1772. [PMID: 12781535 DOI: 10.1016/s0140-6736(03)13412-5] [Cited by in Crossref: 1509] [Cited by in F6Publishing: 1111] [Article Influence: 79.4] [Reference Citation Analysis]
205 Zhong NS, Wong GW. Epidemiology of severe acute respiratory syndrome (SARS): adults and children. Paediatr Respir Rev 2004;5:270-4. [PMID: 15531250 DOI: 10.1016/j.prrv.2004.07.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
206 Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, Farzan M, Wohlford-Lenane C, Perlman S, McCray PB Jr. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005;79:14614-14621. [PMID: 16282461 DOI: 10.1128/jvi.79.23.14614-14621.2005] [Cited by in Crossref: 481] [Cited by in F6Publishing: 329] [Article Influence: 30.1] [Reference Citation Analysis]
207 Khanolkar A, Hartwig SM, Haag BA, Meyerholz DK, Epping LL, Haring JS, Varga SM, Harty JT. Protective and pathologic roles of the immune response to mouse hepatitis virus type 1: implications for severe acute respiratory syndrome. J Virol 2009;83:9258-72. [PMID: 19570864 DOI: 10.1128/JVI.00355-09] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
208 Samaranayake LP, Peiris M. Severe acute respiratory syndrome and dentistry: a retrospective view. J Am Dent Assoc 2004;135:1292-302. [PMID: 15493394 DOI: 10.14219/jada.archive.2004.0405] [Cited by in Crossref: 72] [Cited by in F6Publishing: 55] [Article Influence: 4.0] [Reference Citation Analysis]
209 Mazzulli T, Farcas GA, Poutanen SM, Willey BM, Low DE, Butany J, Asa SL, Kain KC. Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerg Infect Dis 2004;10:20-4. [PMID: 15078592 DOI: 10.3201/eid1001.030404] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
210 Fujii T, Nakamura T, Iwamoto A. Current concepts in SARS treatment. J Infect Chemother 2004;10:1-7. [PMID: 14991510 DOI: 10.1007/s10156-003-0296-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
211 Drosten C, Preiser W, Günther S, Schmitz H, Doerr HW. Severe acute respiratory syndrome: identification of the etiological agent. Trends Mol Med 2003;9:325-7. [PMID: 12928032 DOI: 10.1016/s1471-4914(03)00133-3] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 3.9] [Reference Citation Analysis]
212 Poon LL, Chan KH, Wong OK, Yam WC, Yuen KY, Guan Y, Lo YM, Peiris JS. Early diagnosis of SARS coronavirus infection by real time RT-PCR. J Clin Virol 2003;28:233-8. [PMID: 14522060 DOI: 10.1016/j.jcv.2003.08.004] [Cited by in Crossref: 132] [Cited by in F6Publishing: 119] [Article Influence: 7.3] [Reference Citation Analysis]
213 Jamieson DJ, Ellis JE, Jernigan DB, Treadwell TA. Emerging infectious disease outbreaks: old lessons and new challenges for obstetrician-gynecologists. Am J Obstet Gynecol 2006;194:1546-55. [PMID: 16731070 DOI: 10.1016/j.ajog.2005.06.062] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
214 Shao PL, Hsueh PR, Chang LY, Lu CY, Kao CL, Chiang YP, Huang HY, Huang FY, Lee CY, Chang LJ, Wu TC, Huang LM; SARS Research Group of National Taiwan University College of Medicine., National Taiwan University Hospital. Development of immunoglobulin G enzyme-linked immunosorbent assay for the serodiagnosis of severe acute respiratory syndrome. J Biomed Sci 2005;12:59-64. [PMID: 15864739 DOI: 10.1007/s11373-004-8184-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
215 Tompa DR, Immanuel A, Srikanth S, Kadhirvel S. Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs. Int J Biol Macromol 2021;172:524-41. [PMID: 33454328 DOI: 10.1016/j.ijbiomac.2021.01.076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
216 Atif M, Malik I. Why is Pakistan vulnerable to COVID-19 associated morbidity and mortality? A scoping review. Int J Health Plann Manage 2020;35:1041-54. [PMID: 32700410 DOI: 10.1002/hpm.3016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
217 de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523-534. [PMID: 27344959 DOI: 10.1038/nrmicro.2016.81] [Cited by in Crossref: 1666] [Cited by in F6Publishing: 1484] [Article Influence: 277.7] [Reference Citation Analysis]
218 Safdar A, Chemaly RF, Perego CA, Gonzalez VR, Rolston KV, Raad II, Tarrand JJ, Callender DL. Hospitalization of an oncology patient suspected of having severe acute respiratory syndrome: a setup for an infection control quagmire at a comprehensive cancer center. Cancer 2003;98:2738-9. [PMID: 14669300 DOI: 10.1002/cncr.11862] [Reference Citation Analysis]
219 Li L, Wo J, Shao J, Zhu H, Wu N, Li M, Yao H, Hu M, Dennin RH. SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients. J Clin Virol 2003;28:239-44. [PMID: 14522061 DOI: 10.1016/s1386-6532(03)00195-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
220 Lu HY, Xu XY, Lei Y, Wu YF, Chen BW, Xiao F, Xie GQ, Han DM. Clinical characteristics and staging of SARS: A report of 801 cases in Beijing. Shijie Huaren Xiaohua Zazhi 2004; 12(5): 1144-1148 [DOI: 10.11569/wcjd.v12.i5.1144] [Reference Citation Analysis]
221 Schwartz I, Boesen ME, Cerchiaro G, Doram C, Edwards BD, Ganesh A, Greenfield J, Jamieson S, Karnik V, Kenney C, Lim R, Menon BK, Mponponsuo K, Rathwell S, Ryckborst KJ, Stewart B, Yaskina M, Metz L, Richer L, Hill MD; ALBERTA HOPE COVID-19 Collaborators. Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trial. CMAJ Open 2021;9:E693-702. [PMID: 34145052 DOI: 10.9778/cmajo.20210069] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
222 Lim WS, Anderson SR, Read RC; SARS Guidelines Committee of the British Thoracic Society; British Infection Society; Health Protection Agency. Hospital management of adults with severe acute respiratory syndrome (SARS) if SARS re-emerges--updated 10 February 2004. J Infect. 2004;49:1-7. [PMID: 15194240 DOI: 10.1016/j.jinf.2004.04.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
223 Holmes KV. SARS coronavirus: a new challenge for prevention and therapy. J Clin Invest 2003;111:1605-9. [PMID: 12782660 DOI: 10.1172/JCI18819] [Cited by in Crossref: 130] [Cited by in F6Publishing: 112] [Article Influence: 6.8] [Reference Citation Analysis]
224 Hsu LY, Lee CC, Green JA, Ang B, Paton NI, Lee L, Villacian JS, Lim PL, Earnest A, Leo YS. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis. 2003;9:713-717. [PMID: 12781012 DOI: 10.3201/eid0906.030264] [Cited by in Crossref: 169] [Cited by in F6Publishing: 163] [Article Influence: 8.9] [Reference Citation Analysis]
225 Chiang CH, Shih JF, Su WJ, Perng RP. Eight-month prospective study of 14 patients with hospital-acquired severe acute respiratory syndrome. Mayo Clin Proc 2004;79:1372-9. [PMID: 15544014 DOI: 10.4065/79.11.1372] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
226 Brierley I, Dos Ramos FJ. Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV. Virus Res 2006;119:29-42. [PMID: 16310880 DOI: 10.1016/j.virusres.2005.10.008] [Cited by in Crossref: 104] [Cited by in F6Publishing: 108] [Article Influence: 6.1] [Reference Citation Analysis]
227 Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004;203:631-7. [PMID: 15141377 DOI: 10.1002/path.1570] [Reference Citation Analysis]
228 Liu G, Hu S, Hu Y, Chen P, Yin J, Wen J, Wang J, Lin L, Liu J, You B, Yin Y, Li S, Wang H, Ren Y, Ji J, Zhao X, Sun Y, Zhang X, Fang J, Wang J, Liu S, Yu J, Zhu H, Yang H. The C-terminal portion of the nucleocapsid protein demonstrates SARS-CoV antigenicity. Genomics Proteomics Bioinformatics 2003;1:193-7. [PMID: 15629031 DOI: 10.1016/s1672-0229(03)01024-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
229 Badaloni S, Falda M. Temporal-based medical diagnoses using a Fuzzy Temporal Reasoning System. J Intell Manuf 2010;21:145-53. [DOI: 10.1007/s10845-008-0171-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
230 Gretebeck LM, Subbarao K. Animal models for SARS and MERS coronaviruses. Curr Opin Virol. 2015;13:123-129. [PMID: 26184451 DOI: 10.1016/j.coviro.2015.06.009] [Cited by in Crossref: 108] [Cited by in F6Publishing: 97] [Article Influence: 15.4] [Reference Citation Analysis]
231 Chen MI, Chow AL, Earnest A, Leong HN, Leo YS. Clinical and epidemiological predictors of transmission in Severe Acute Respiratory Syndrome (SARS). BMC Infect Dis 2006;6:151. [PMID: 17049088 DOI: 10.1186/1471-2334-6-151] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
232 Wang Y, Wang Y, Han X, Ye J, Li R. Potential Effect of COVID-19 on Maternal and Infant Outcome: Lesson From SARS. Front Pediatr 2020;8:511. [PMID: 32850564 DOI: 10.3389/fped.2020.00511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
233 Wong T, Wallington T, McDonald LC, Abbas Z, Christian M, Low DE, Gravel D, Ofner M, Mederski B, Berger L, Hansen L, Harrison C, King A, Yaffe B, Tam T. Late recognition of SARS in nosocomial outbreak, Toronto. Emerg Infect Dis 2005;11:322-5. [PMID: 15752456 DOI: 10.3201/eid1102.040607] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
234 McDermott JE, Mitchell HD, Gralinski LE, Eisfeld AJ, Josset L, Bankhead A 3rd, Neumann G, Tilton SC, Schäfer A, Li C, Fan S, McWeeney S, Baric RS, Katze MG, Waters KM. The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus. BMC Syst Biol 2016;10:93. [PMID: 27663205 DOI: 10.1186/s12918-016-0336-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
235 Haghani M, Varamini P. Temporal evolution, most influential studies and sleeping beauties of the coronavirus literature. Scientometrics 2021;:1-46. [PMID: 34188334 DOI: 10.1007/s11192-021-04036-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Bakhshandeh B, Sorboni SG, Javanmard AR, Mottaghi SS, Mehrabi MR, Sorouri F, Abbasi A, Jahanafrooz Z. Variants in ACE2; potential influences on virus infection and COVID-19 severity. Infect Genet Evol 2021;90:104773. [PMID: 33607284 DOI: 10.1016/j.meegid.2021.104773] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
237 Pancer KW. Pandemic Human Coronavirus – characterization and comparison of selected properties of HCoV-SARS and HCoV-MERS. Postępy Mikrobiologii - Advancements of Microbiology 2018;57:22-32. [DOI: 10.21307/pm-2018.57.1.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
238 Williams JV, Tollefson SJ, Johnson JE, Crowe JE Jr. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity. J Virol 2005;79:10944-51. [PMID: 16103146 DOI: 10.1128/JVI.79.17.10944-10951.2005] [Cited by in Crossref: 84] [Cited by in F6Publishing: 58] [Article Influence: 4.9] [Reference Citation Analysis]
239 Cinatl J Jr, Michaelis M, Scholz M, Doerr HW. Role of interferons in the treatment of severe acute respiratory syndrome. Expert Opin Biol Ther. 2004;4:827-836. [PMID: 15174965 DOI: 10.1517/14712598.4.6.827] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
240 Muller MP, Richardson SE, McGeer A, Dresser L, Raboud J, Mazzulli T, Loeb M, Louie M;  Canadian SARS Research Network. Early diagnosis of SARS: lessons from the Toronto SARS outbreak. Eur J Clin Microbiol Infect Dis. 2006;25:230-237. [PMID: 16586072 DOI: 10.1007/s10096-006-0127-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
241 Peng PW, Wong DT, Bevan D, Gardam M. Infection control and anesthesia: lessons learned from the Toronto SARS outbreak. Can J Anaesth 2003;50:989-97. [PMID: 14656775 DOI: 10.1007/BF03018361] [Cited by in Crossref: 47] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
242 Zheng WX, Chen LL, Ou HY, Gao F, Zhang CT. Coronavirus phylogeny based on a geometric approach. Mol Phylogenet Evol 2005;36:224-32. [PMID: 15890535 DOI: 10.1016/j.ympev.2005.03.030] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
243 Fan S, Blair C, Brown A, Gabos S, Honish L, Hughes T, Jaipaul J, Johnson M, Lo E, Lubchenko A, Mashinter L, Meurer DP, Nardelli V, Predy G, Shewchuk L, Sosin D, Wicentowich B, Talbot J. A Multi-function Public Health Surveillance System and the Lessons Learned in Its Development: The Alberta Real Time Syndromic Surveillance Net. Can J Public Health 2010;101:454-8. [DOI: 10.1007/bf03403963] [Cited by in Crossref: 13] [Article Influence: 1.1] [Reference Citation Analysis]
244 Adedeji AO, Severson W, Jonsson C, Singh K, Weiss SR, Sarafianos SG. Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms. J Virol 2013;87:8017-28. [PMID: 23678171 DOI: 10.1128/JVI.00998-13] [Cited by in Crossref: 103] [Cited by in F6Publishing: 78] [Article Influence: 11.4] [Reference Citation Analysis]
245 Fan Z, Peng K, Tan X, Yin B, Dong X, Qiu F, Shen Y, Wang H, Yuan J, Qiang B, Peng X. Molecular cloning, expression, and purification of SARS-CoV nsp13. Protein Expr Purif 2005;41:235-40. [PMID: 15866708 DOI: 10.1016/j.pep.2004.08.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
246 Liu CL, Lu YT, Peng MJ, Chen PJ, Lin RL, Wu CL, Kuo HT. Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever. Chest 2004;126:509-17. [PMID: 15302738 DOI: 10.1378/chest.126.2.509] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 2.4] [Reference Citation Analysis]
247 Huang JL, Lin HT, Wang YM, Yeh YC, Peck K, Lin BL, Liu HW, Chen A, Lin CS. Rapid and sensitive detection of multiple genes from the SARS-coronavirus using quantitative RT-PCR with dual systems. J Med Virol 2005;77:151-8. [PMID: 16121372 DOI: 10.1002/jmv.20432] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
248 MacDonald RD, Farr B, Neill M, Loch J, Sawadsky B, Mazza C, Daya K, Olynyk C, Chad S. An emergency medical services transfer authorization center in response to the Toronto severe acute respiratory syndrome outbreak. Prehosp Emerg Care 2004;8:223-31. [PMID: 15060861 DOI: 10.1016/j.prehos.2003.12.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
249 Rovida F, Percivalle E, Zavattoni M, Torsellini M, Sarasini A, Campanini G, Paolucci S, Baldanti F, Revello MG, Gerna G. Monoclonal antibodies versus reverse transcription-PCR for detection of respiratory viruses in a patient population with respiratory tract infections admitted to hospital. J Med Virol 2005;75:336-47. [PMID: 15602736 DOI: 10.1002/jmv.20276] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
250 Leung DT, Tam FC, Ma CH, Chan PK, Cheung JL, Niu H, Tam JS, Lim PL. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J Infect Dis 2004;190:379-86. [PMID: 15216476 DOI: 10.1086/422040] [Cited by in Crossref: 140] [Cited by in F6Publishing: 125] [Article Influence: 7.8] [Reference Citation Analysis]
251 Gerna G, Vitulo P, Rovida F, Lilleri D, Pellegrini C, Oggionni T, Campanini G, Baldanti F, Revello MG. Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. J Med Virol 2006;78:408-16. [PMID: 16419110 DOI: 10.1002/jmv.20555] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 4.6] [Reference Citation Analysis]
252 Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, Martin KA, Chun HJ, Hwa J. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol 2021;18:194-209. [PMID: 33214651 DOI: 10.1038/s41569-020-00469-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 24.5] [Reference Citation Analysis]
253 Wilder-Smith A, Earnest A, Paton NI. Use of simple laboratory features to distinguish the early stage of severe acute respiratory syndrome from dengue fever. Clin Infect Dis 2004;39:1818-23. [PMID: 15578405 DOI: 10.1086/426029] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
254 Adedeji AO, Singh K, Calcaterra NE, DeDiego ML, Enjuanes L, Weiss S, Sarafianos SG. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase. Antimicrob Agents Chemother 2012;56:4718-28. [PMID: 22733076 DOI: 10.1128/AAC.00957-12] [Cited by in Crossref: 65] [Cited by in F6Publishing: 43] [Article Influence: 6.5] [Reference Citation Analysis]
255 Guery B, d'Escrivan T, Georges H, Legout L, Leroy O, Viget N, Faure K. [Viral pneumonia in immunocompetent patients]. Reanimation 2004;13:226-37. [PMID: 32288722 DOI: 10.1016/j.reaurg.2004.02.009] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
256 Pourbohloul B, Meyers LA, Skowronski DM, Krajden M, Patrick DM, Brunham RC. Modeling control strategies of respiratory pathogens. Emerg Infect Dis 2005;11:1249-56. [PMID: 16102315 DOI: 10.3201/eid1108.040449] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 3.8] [Reference Citation Analysis]
257 Emery SL, Erdman DD, Bowen MD, Newton BR, Winchell JM, Meyer RF, Tong S, Cook BT, Holloway BP, McCaustland KA, Rota PA, Bankamp B, Lowe LE, Ksiazek TG, Bellini WJ, Anderson LJ. Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis 2004;10:311-6. [PMID: 15030703 DOI: 10.3201/eid1002.030759] [Cited by in Crossref: 159] [Cited by in F6Publishing: 141] [Article Influence: 8.8] [Reference Citation Analysis]
258 Singh B. Innovation and challenges in funding rapid research responses to emerging infectious diseases: Lessons learned from the outbreak of severe acute respiratory syndrome. Can J Infect Dis Med Microbiol 2004;15:167-70. [PMID: 18159488 DOI: 10.1155/2004/925872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
259 Wong WC, Lee A, Tsang KK, Wong SY. How did general practitioners protect themselves, their family, and staff during the SARS epidemic in Hong Kong? J Epidemiol Community Health 2004;58:180-5. [PMID: 14966227 DOI: 10.1136/jech.2003.015594] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
260 Lam WK, Zhong NS, Tan WC. Overview on SARS in Asia and the world. Respirology. 2003;8 Suppl:S2-S5. [PMID: 15018125 DOI: 10.1046/j.1440-1843.2003.00516.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
261 Isakbaeva ET, Khetsuriani N, Beard RS, Peck A, Erdman D, Monroe SS, Tong S, Ksiazek TG, Lowther S, Pandya-Smith I, Anderson LJ, Lingappa J, Widdowson MA; SARS Investigation Group. SARS-associated coronavirus transmission, United States. Emerg Infect Dis 2004;10:225-31. [PMID: 15030687 DOI: 10.3201/eid1002.030734] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
262 Gebbie EN, Morse SS, Hanson H, McCollum MC, Reddy V, Gebbie KM, Smailes E, Balter S. Training for and maintaining public health surge capacity: a program for disease outbreak investigation by student volunteers. Public Health Rep 2007;122:127-33. [PMID: 17236619 DOI: 10.1177/003335490712200119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
263 He Z, Zhao C, Dong Q, Zhuang H, Song S, Peng G, Dwyer DE. Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. Int J Infect Dis 2005;9:323-30. [PMID: 16095942 DOI: 10.1016/j.ijid.2004.07.014] [Cited by in Crossref: 115] [Cited by in F6Publishing: 106] [Article Influence: 6.8] [Reference Citation Analysis]
264 Christian MD, Loutfy M, McDonald LC, Martinez KF, Ofner M, Wong T, Wallington T, Gold WL, Mederski B, Green K, Low DE; SARS Investigation Team. Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis 2004;10:287-93. [PMID: 15030699 DOI: 10.3201/eid1002.030700] [Cited by in Crossref: 170] [Cited by in F6Publishing: 138] [Article Influence: 9.4] [Reference Citation Analysis]
265 Adachi D, Johnson G, Draker R, Ayers M, Mazzulli T, Talbot PJ, Tellier R. Comprehensive detection and identification of human coronaviruses, including the SARS-associated coronavirus, with a single RT-PCR assay. J Virol Methods 2004;122:29-36. [PMID: 15488617 DOI: 10.1016/j.jviromet.2004.07.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
266 Chan PK, Tam JS, Lam CW, Chan E, Wu A, Li CK, Buckley TA, Ng KC, Joynt GM, Cheng FW, To KF, Lee N, Hui DS, Cheung JL, Chu I, Liu E, Chung SS, Sung JJ. Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1058-63. [PMID: 14519240 DOI: 10.3201/eid0909.030304] [Cited by in Crossref: 94] [Cited by in F6Publishing: 83] [Article Influence: 4.9] [Reference Citation Analysis]
267 Nguyen-Van-Tam JS, Sellwood C. Intervention strategies for emerging respiratory virus infections: policy and public health considerations. Curr Opin Virol 2013;3:192-8. [PMID: 23477831 DOI: 10.1016/j.coviro.2013.02.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
268 Parker MJ, Goldman RD. Paediatric emergency department staff perceptions of infection control measures against severe acute respiratory syndrome. Emerg Med J 2006;23:349-53. [PMID: 16627834 DOI: 10.1136/emj.2005.026146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
269 Vadlamani BS, Uppal T, Verma SC, Misra M. Functionalized TiO2 Nanotube-Based Electrochemical Biosensor for Rapid Detection of SARS-CoV-2. Sensors (Basel) 2020;20:E5871. [PMID: 33080785 DOI: 10.3390/s20205871] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 19.0] [Reference Citation Analysis]
270 Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, Li X, Xu P, Zhang L, Zhao L, Cao Y, Kang J, Yang J, Li L, Liu X, Li Y, Nie R, Mu J, Lu F, Zhao S, Lu J, Zhao J. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020;73:807-816. [PMID: 32437830 DOI: 10.1016/j.jhep.2020.05.002] [Cited by in Crossref: 158] [Cited by in F6Publishing: 161] [Article Influence: 79.0] [Reference Citation Analysis]
271 Liu RS, Yang KY, Lin J, Lin YW, Zhang ZH, Zhang J, Xia NS. High-yield expression of recombinant SARS coronavirus nucleocapsid protein in methylotrophic yeast Pichia pastorisWorld J Gastroenterol 2004; 10(24): 3602-3607 [PMID: 15534914 DOI: 10.3748/wjg.v10.i24.3602] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
272 André M, Talarmin F, Le Guen P, Nicolas X, Garcia JF, Natali F. [Asymptomatic forms of the Severe Acute Respiratory Syndrome (SARS)]. Rev Mal Respir 2005;22:135-41. [PMID: 15968766 DOI: 10.1016/s0761-8425(05)85444-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
273 Chen KT, Twu SJ, Chang HL, Wu YC, Chen CT, Lin TH, Olsen SJ, Dowell SF, Su IJ; Taiwan SARS Response Team. SARS in Taiwan: an overview and lessons learned. Int J Infect Dis 2005;9:77-85. [PMID: 15708322 DOI: 10.1016/j.ijid.2004.04.015] [Cited by in Crossref: 60] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
274 Tsang KW, File TM Jr. Respiratory infections unique to Asia. Respirology 2008;13:937-49. [PMID: 18945321 DOI: 10.1111/j.1440-1843.2008.01409.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
275 Maxwell C, McGeer A, Tai KFY, Sermer M; MATERNAL FETAL MEDICINE COMMITTEE., INFECTIOUS DISEASE COMMITTEE. Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS). J Obstet Gynaecol Can 2009;31:358-64. [PMID: 19497157 DOI: 10.1016/S1701-2163(16)34155-X] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
276 Sampath R, Hofstadler SA, Blyn LB, Eshoo MW, Hall TA, Massire C, Levene HM, Hannis JC, Harrell PM, Neuman B, Buchmeier MJ, Jiang Y, Ranken R, Drader JJ, Samant V, Griffey RH, McNeil JA, Crooke ST, Ecker DJ. Rapid identification of emerging pathogens: coronavirus. Emerg Infect Dis 2005;11:373-9. [PMID: 15757550 DOI: 10.3201/eid1103.040629] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 4.6] [Reference Citation Analysis]
277 Liatsos GD. Controversies’ clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages. World J Clin Cases 2021; 9(19): 5135-5178 [PMID: 34307564 DOI: 10.12998/wjcc.v9.i19.5135] [Reference Citation Analysis]
278 Shiu SY, Reiter RJ, Tan DX, Pang SF. Urgent search for safe and effective treatments of severe acute respiratory syndrome: is melatonin a promising candidate drug? J Pineal Res 2003;35:69-70. [PMID: 12823616 DOI: 10.1034/j.1600-079x.2003.00068.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
279 Bansal S, Grenfell BT, Meyers LA. When individual behaviour matters: homogeneous and network models in epidemiology. J R Soc Interface 2007;4:879-91. [PMID: 17640863 DOI: 10.1098/rsif.2007.1100] [Cited by in Crossref: 405] [Cited by in F6Publishing: 301] [Article Influence: 27.0] [Reference Citation Analysis]
280 Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, Butany J. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest 2009;39:618-25. [PMID: 19453650 DOI: 10.1111/j.1365-2362.2009.02153.x] [Cited by in Crossref: 460] [Cited by in F6Publishing: 415] [Article Influence: 35.4] [Reference Citation Analysis]
281 Guzman MI. An overview of the effect of bioaerosol size in coronavirus disease 2019 transmission. Int J Health Plann Manage 2021;36:257-66. [PMID: 33295073 DOI: 10.1002/hpm.3095] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
282 Vardhana SA, Wolchok JD. The many faces of the anti-COVID immune response. J Exp Med 2020;217:e20200678. [PMID: 32353870 DOI: 10.1084/jem.20200678] [Cited by in Crossref: 243] [Cited by in F6Publishing: 230] [Article Influence: 121.5] [Reference Citation Analysis]
283 Gerna G, Campanini G, Rovida F, Sarasini A, Lilleri D, Paolucci S, Marchi A, Baldanti F, Revello MG. Changing circulation rate of human metapneumovirus strains and types among hospitalized pediatric patients during three consecutive winter-spring seasons. Brief report. Arch Virol 2005;150:2365-75. [PMID: 15986171 DOI: 10.1007/s00705-005-0581-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
284 Humar A, McGilvray I, Phillips MJ, Levy GA. Severe acute respiratory syndrome and the liver. Hepatology 2004;39:291-4. [PMID: 14767979 DOI: 10.1002/hep.20069] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
285 Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, Lit LC, Hui DS, Chan MH, Chung SS, Sung JJ. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004;136:95-103. [PMID: 15030519 DOI: 10.1111/j.1365-2249.2004.02415.x] [Cited by in Crossref: 742] [Cited by in F6Publishing: 701] [Article Influence: 41.2] [Reference Citation Analysis]
286 Chiu SC, Lin YC, Wang HC, Hsu JJ, Yeh TK, Liu HF, Lin JH. Surveillance of upper respiratory infections using a new multiplex PCR assay compared to conventional methods during the influenza season in Taiwan. Int J Infect Dis 2017;61:97-102. [PMID: 28625839 DOI: 10.1016/j.ijid.2017.06.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
287 Cherry JD. The chronology of the 2002-2003 SARS mini pandemic. Paediatr Respir Rev 2004;5:262-9. [PMID: 15531249 DOI: 10.1016/j.prrv.2004.07.009] [Cited by in Crossref: 69] [Cited by in F6Publishing: 52] [Article Influence: 3.8] [Reference Citation Analysis]
288 Berger A, Drosten Ch, Doerr HW, Stürmer M, Preiser W. Severe acute respiratory syndrome (SARS)--paradigm of an emerging viral infection. J Clin Virol 2004;29:13-22. [PMID: 14675864 DOI: 10.1016/j.jcv.2003.09.011] [Cited by in Crossref: 81] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
289 Rajakaruna SJ, Liu WB, Ding YB, Cao GW. Strategy and technology to prevent hospital-acquired infections: Lessons from SARS, Ebola, and MERS in Asia and West Africa. Mil Med Res 2017;4:32. [PMID: 29502517 DOI: 10.1186/s40779-017-0142-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
290 Breiman RF, Evans MR, Preiser W, Maguire J, Schnur A, Li A, Bekedam H, MacKenzie JS. Role of China in the quest to define and control severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1037-41. [PMID: 14519236 DOI: 10.3201/eid0909.030390] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
291 Bai B, Hu Q, Hu H, Zhou P, Shi Z, Meng J, Lu B, Huang Y, Mao P, Wang H. Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells. PLoS One 2008;3:e2685. [PMID: 18628832 DOI: 10.1371/journal.pone.0002685] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
292 Chen X, Zhou B, Li M, Liang X, Wang H, Yang G, Wang H, Le X. Serology of severe acute respiratory syndrome: implications for surveillance and outcome. J Infect Dis 2004;189:1158-63. [PMID: 15031782 DOI: 10.1086/380397] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
293 Guo Y, Cao Q, Hong Z, Tan Y, Chen S, Jin H, Tan K, Wang D, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Med Res 2020;7. [DOI: 10.1186/s40779-020-00240-0] [78495111110.1186/s40779-020-00240-0','', '1007-9327')">Reference Citation Analysis]
294 Berry M, Gamieldien J, Fielding BC. Identification of new respiratory viruses in the new millennium. Viruses 2015;7:996-1019. [PMID: 25757061 DOI: 10.3390/v7030996] [Cited by in Crossref: 85] [Cited by in F6Publishing: 71] [Article Influence: 12.1] [Reference Citation Analysis]
295 Kwong JC, Stukel TA, McGeer AJ, Manuel DG. Appropriate measures of influenza immunization program effectiveness. Vaccine 2007;25:967-9. [PMID: 17052813 DOI: 10.1016/j.vaccine.2006.09.080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
296 Xu J, Zhao S, Teng T, Abdalla AE, Zhu W, Xie L, Wang Y, Guo X. Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses. 2020;12. [PMID: 32098422 DOI: 10.3390/v12020244] [Cited by in Crossref: 302] [Cited by in F6Publishing: 278] [Article Influence: 151.0] [Reference Citation Analysis]
297 Li RW, Leung KW, Sun FC, Samaranayake LP. Severe acute respiratory syndrome (SARS) and the GDP. Part II: implications for GDPs. Br Dent J 2004;197:130-4. [PMID: 15311240 DOI: 10.1038/sj.bdj.4811522] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
298 Wenzel RP, Bearman G, Edmond MB. Lessons from severe acute respiratory syndrome (SARS): implications for infection control. Arch Med Res 2005;36:610-6. [PMID: 16216641 DOI: 10.1016/j.arcmed.2005.03.040] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
299 Chow KY, Lee CE, Ling ML, Heng DM, Yap SG. Outbreak of severe acute respiratory syndrome in a tertiary hospital in Singapore, linked to an index patient with atypical presentation: epidemiological study. BMJ 2004;328:195. [PMID: 14726369 DOI: 10.1136/bmj.37939.465729.44] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
300 Augustine JJ, Kellermann AL, Koplan JP. America's emergency care system and severe acute respiratory syndrome: are we ready? Ann Emerg Med 2004;43:23-6. [PMID: 14707936 DOI: 10.1016/j.annemergmed.2003.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
301 Singh K, Eong OE, Kumarsil B, Saw S, Sethi S. Severe acute respiratory syndrome without respiratory symptoms or abnormal chest radiograph findings. Clin Infect Dis 2004;38:585-6. [PMID: 14765354 DOI: 10.1086/381437] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
302 Cheng VC, Chan JF, To KK, Yuen KY. Clinical management and infection control of SARS: lessons learned. Antiviral Res 2013;100:407-19. [PMID: 23994190 DOI: 10.1016/j.antiviral.2013.08.016] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 10.0] [Reference Citation Analysis]
303 De Albuquerque N, Baig E, Ma X, Zhang J, He W, Rowe A, Habal M, Liu M, Shalev I, Downey GP. Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice. J Virol. 2006;80:10382-10394. [PMID: 17041219 DOI: 10.1128/jvi.00747-06] [Cited by in Crossref: 91] [Cited by in F6Publishing: 66] [Article Influence: 5.7] [Reference Citation Analysis]
304 Kashani NR, Azadbakht J, Ehteram H, Kashani HH, Rajabi-moghadam H, Ahmad E, Nikzad H, Hosseini ES. Molecular and Clinical Investigation of COVID-19: From Pathogenesis and Immune Responses to Novel Diagnosis and Treatment. Front Mol Biosci 2022;9:770775. [DOI: 10.3389/fmolb.2022.770775] [Reference Citation Analysis]
305 Chim SS, Chiu RW, Lo YM. Genomic sequencing of the severe acute respiratory syndrome-coronavirus. Methods Mol Biol 2006;336:177-94. [PMID: 16916263 DOI: 10.1385/1-59745-074-X:177] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
306 Finlay BB, See RH, Brunham RC. Rapid response research to emerging infectious diseases: lessons from SARS. Nat Rev Microbiol 2004;2:602-7. [PMID: 15197395 DOI: 10.1038/nrmicro930] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
307 Dutronc H, Dupon M, Cipriano G, Lafarie S, Lafon ME, Fleury HJ, Bocquentin F, Neau D, Ragnaud JM. [Severe acute respiratory syndrome: one case of indirect transmission by Coronavirus]. Rev Med Interne 2004;25:607-9. [PMID: 15276297 DOI: 10.1016/j.revmed.2004.05.001] [Reference Citation Analysis]
308 Tee AK, Oh HM, Lien CT, Narendran K, Heng BH, Ling AE. Atypical SARS in geriatric patient. Emerg Infect Dis 2004;10:261-4. [PMID: 15030694 DOI: 10.3201/eid1002.030322] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
309 Ho JS, Tambyah PA, Ho AF, Chan MY, Sia CH. Effect of coronavirus infection on the human heart: A scoping review. Eur J Prev Cardiol 2020;27:1136-48. [PMID: 32423250 DOI: 10.1177/2047487320925965] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
310 Rabenau HF, Cinatl J, Morgenstern B, Bauer G, Preiser W, Doerr HW. Stability and inactivation of SARS coronavirus. Med Microbiol Immunol. 2005;194:1-6. [PMID: 15118911 DOI: 10.1007/s00430-004-0219-0] [Cited by in Crossref: 298] [Cited by in F6Publishing: 267] [Article Influence: 17.5] [Reference Citation Analysis]
311 Kim SB, Huh K, Heo JY, Joo EJ, Kim YJ, Choi WS, Kim YJ, Seo YB, Yoon YK, Ku NS, Jeong SJ, Kim SH, Peck KR, Yeom JS. Interim Guidelines on Antiviral Therapy for COVID-19. Infect Chemother 2020;52:281-304. [PMID: 32342676 DOI: 10.3947/ic.2020.52.2.281] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
312 Kwan BC, Leung CB, Szeto CC, Wang AY, Li PK. Severe acute respiratory syndrome in a hemodialysis patient. Am J Kidney Dis 2003;42:1069-74. [PMID: 14582051 DOI: 10.1016/j.ajkd.2003.07.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
313 Keyaerts E, Vijgen L, Maes P, Duson G, Neyts J, Van Ranst M. Viral load quantitation of SARS-coronavirus RNA using a one-step real-time RT-PCR. Int J Infect Dis 2006;10:32-7. [PMID: 16023880 DOI: 10.1016/j.ijid.2005.02.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
314 Domínguez A, Gudiol F, Pumarola T, Salleras L. [Severe acute respiratory syndrome epidemics: the end or a hiatus of the epidemic?]. Med Clin (Barc) 2003;121:340-6. [PMID: 14499072 DOI: 10.1016/s0025-7753(03)73942-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
315 Lin CW, Tsai FJ, Tsai CH, Lai CC, Wan L, Ho TY, Hsieh CC, Chao PD. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res 2005;68:36-42. [PMID: 16115693 DOI: 10.1016/j.antiviral.2005.07.002] [Cited by in Crossref: 223] [Cited by in F6Publishing: 197] [Article Influence: 13.9] [Reference Citation Analysis]
316 Lang ZW, Zhang LJ, Zhang SJ, Meng X, Li JQ, Song CZ, Sun L, Zhou YS, Dwyer DE. A clinicopathological study of three cases of severe acute respiratory syndrome (SARS). Pathology 2003;35:526-31. [PMID: 14660106 DOI: 10.1080/00313020310001619118] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 3.7] [Reference Citation Analysis]
317 Meyers LA, Pourbohloul B, Newman ME, Skowronski DM, Brunham RC. Network theory and SARS: predicting outbreak diversity. J Theor Biol 2005;232:71-81. [PMID: 15498594 DOI: 10.1016/j.jtbi.2004.07.026] [Cited by in Crossref: 442] [Cited by in F6Publishing: 325] [Article Influence: 24.6] [Reference Citation Analysis]
318 Han DP, Kim HG, Kim YB, Poon LL, Cho MW. Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein. Virology 2004;326:140-9. [PMID: 15262502 DOI: 10.1016/j.virol.2004.05.017] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
319 Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, Laman JD, de Jong T, van Doornum G, Lim W. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet. 2003;362:263-270. [PMID: 12892955 DOI: 10.1016/s0140-6736(03)13967-0] [Cited by in Crossref: 693] [Cited by in F6Publishing: 550] [Article Influence: 36.5] [Reference Citation Analysis]
320 Mao C, Yu Z, Li C, Jin Y, Ma M. The Functional Properties of Preserved Eggs: From Anti-cancer and Anti-inflammatory Aspects. Korean J Food Sci Anim Resour 2018;38:615-28. [PMID: 30018504 DOI: 10.5851/kosfa.2018.38.3.615] [Reference Citation Analysis]
321 Leung C, Kwan Y, Ko P, Chiu SS, Loung P, Fong N, Lee L, Hui Y, Law HKW, Wong WHS, Chan K, Peiris JSM, Lim WWL, Lau Y, Chiu M. Severe Acute Respiratory Syndrome Among Children. PEDIATRICS 2004;113:e535-43. [DOI: 10.1542/peds.113.6.e535] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 4.8] [Reference Citation Analysis]
322 Colizza V, Barrat A, Barthélemy M, Vespignani A. Predictability and epidemic pathways in global outbreaks of infectious diseases: the SARS case study. BMC Med 2007;5:34. [PMID: 18031574 DOI: 10.1186/1741-7015-5-34] [Cited by in Crossref: 111] [Cited by in F6Publishing: 81] [Article Influence: 7.4] [Reference Citation Analysis]
323 Bermingham A, Heinen P, Iturriza-Gómara M, Gray J, Appleton H, Zambon MC. Laboratory diagnosis of SARS. Philos Trans R Soc Lond B Biol Sci 2004;359:1083-9. [PMID: 15306394 DOI: 10.1098/rstb.2004.1493] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
324 Lim EC, Seet RC, Lee KH, Wilder-Smith EP, Chuah BY, Ong BK. Headaches and the N95 face-mask amongst healthcare providers. Acta Neurol Scand 2006;113:199-202. [PMID: 16441251 DOI: 10.1111/j.1600-0404.2005.00560.x] [Cited by in Crossref: 142] [Cited by in F6Publishing: 114] [Article Influence: 8.9] [Reference Citation Analysis]
325 Shanmugam C, Mohammed AR, Ravuri S, Luthra V, Rajagopal N, Karre S. COVID-2019 - A comprehensive pathology insight. Pathol Res Pract. 2020;216:153222. [PMID: 32979742 DOI: 10.1016/j.prp.2020.153222] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
326 Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res 2020;7:11. [PMID: 32169119 DOI: 10.1186/s40779-020-00240-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
327 Earnest A, Chen MI, Ng D, Sin LY. Using autoregressive integrated moving average (ARIMA) models to predict and monitor the number of beds occupied during a SARS outbreak in a tertiary hospital in Singapore. BMC Health Serv Res 2005;5:36. [PMID: 15885149 DOI: 10.1186/1472-6963-5-36] [Cited by in Crossref: 71] [Cited by in F6Publishing: 46] [Article Influence: 4.2] [Reference Citation Analysis]
328 Kleen TO, Galdon AA, MacDonald AS, Dalgleish AG. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends". Front Immunol 2020;11:2059. [PMID: 33013871 DOI: 10.3389/fimmu.2020.02059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
329 Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875-879. [PMID: 16007097 DOI: 10.1038/nm1267] [Cited by in Crossref: 1930] [Cited by in F6Publishing: 1757] [Article Influence: 113.5] [Reference Citation Analysis]
330 Tiwari A, Chan S, Wong A, Tai J, Cheng K, Chan J, Tsang K; Nursing Task Force on Anti-SARS of Queen Mary Hospital. Severe acute respiratory syndrome (SARS) in Hong Kong: patients' experiences. Nurs Outlook 2003;51:212-9. [PMID: 14569227 DOI: 10.1016/j.outlook.2003.07.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
331 Muller MP, McGeer A, Straus SE, Hawryluck L, Gold WL. Clinical trials and novel pathogens: lessons learned from SARS. Emerg Infect Dis 2004;10:389-94. [PMID: 15109402 DOI: 10.3201/eid1003.030702] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
332 Sumino KC, Agapov E, Pierce RA, Trulock EP, Pfeifer JD, Ritter JH, Gaudreault-Keener M, Storch GA, Holtzman MJ. Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment. J Infect Dis 2005;192:1052-60. [PMID: 16107959 DOI: 10.1086/432728] [Cited by in Crossref: 68] [Cited by in F6Publishing: 50] [Article Influence: 4.0] [Reference Citation Analysis]
333 Gao F, Ou HY, Chen LL, Zheng WX, Zhang CT. Prediction of proteinase cleavage sites in polyproteins of coronaviruses and its applications in analyzing SARS-CoV genomes. FEBS Lett 2003;553:451-6. [PMID: 14572668 DOI: 10.1016/s0014-5793(03)01091-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 2.4] [Reference Citation Analysis]
334 Wu CY, King KY, Kuo CJ, Fang JM, Wu YT, Ho MY, Liao CL, Shie JJ, Liang PH, Wong CH. Stable benzotriazole esters as mechanism-based inactivators of the severe acute respiratory syndrome 3CL protease. Chem Biol 2006;13:261-8. [PMID: 16638531 DOI: 10.1016/j.chembiol.2005.12.008] [Cited by in Crossref: 86] [Cited by in F6Publishing: 77] [Article Influence: 5.4] [Reference Citation Analysis]
335 Al-Azzam S, Ding Y, Liu J, Pandya P, Ting JP, Afshar S. Peptides to combat viral infectious diseases. Peptides 2020;134:170402. [PMID: 32889022 DOI: 10.1016/j.peptides.2020.170402] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
336 Wills BS, Morse JM. Responses of Chinese elderly to the threat of severe acute respiratory syndrome (SARS) in a Canadian community. Public Health Nurs 2008;25:57-68. [PMID: 18173586 DOI: 10.1111/j.1525-1446.2008.00680.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
337 Huang Y, Yang ZY, Kong WP, Nabel GJ. Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production. J Virol 2004;78:12557-65. [PMID: 15507643 DOI: 10.1128/JVI.78.22.12557-12565.2004] [Cited by in Crossref: 89] [Cited by in F6Publishing: 76] [Article Influence: 4.9] [Reference Citation Analysis]
338 Chan PK, To WK, Liu EY, Ng TK, Tam JS, Sung JJ, Lacroix JM, Houde M. Evaluation of a peptide-based enzyme immunoassay for anti-SARS coronavirus IgG antibody. J Med Virol 2004;74:517-20. [PMID: 15484283 DOI: 10.1002/jmv.20207] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
339 Cooper BS, Fang LQ, Zhou JP, Feng D, Lv H, Wei MT, Wang SX, Cao WC, de Vlas SJ. Transmission of SARS in three Chinese hospitals. Trop Med Int Health 2009;14 Suppl 1:71-8. [PMID: 19814763 DOI: 10.1111/j.1365-3156.2009.02346.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
340 Al-Tawfiq JA, Azhar EI, Memish ZA, Zumla A. Middle East Respiratory Syndrome Coronavirus. Semin Respir Crit Care Med 2021;42:828-38. [PMID: 34918324 DOI: 10.1055/s-0041-1733804] [Reference Citation Analysis]
341 Wang TH, Wei KC, Hsiung CA, Maloney SA, Eidex RB, Posey DL, Chou WH, Shih WY, Kuo HS. Optimizing severe acute respiratory syndrome response strategies: lessons learned from quarantine. Am J Public Health 2007;97 Suppl 1:S98-100. [PMID: 17413071 DOI: 10.2105/AJPH.2005.082115] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
342 Momattin H, Mohammed K, Zumla A, Memish ZA, Al-Tawfiq JA. Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis 2013;17:e792-8. [PMID: 23993766 DOI: 10.1016/j.ijid.2013.07.002] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 9.0] [Reference Citation Analysis]
343 Ohara H. Contribution of technical guidance on nosocomial infection control to the containment of Severe Acute Respiratory Syndrome in Vietnam. Int Congr Ser 2004;1267:79-87. [PMID: 32288147 DOI: 10.1016/j.ics.2004.01.086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
344 Booth TF, Kournikakis B, Bastien N, Ho J, Kobasa D, Stadnyk L, Li Y, Spence M, Paton S, Henry B, Mederski B, White D, Low DE, McGeer A, Simor A, Vearncombe M, Downey J, Jamieson FB, Tang P, Plummer F. Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. J Infect Dis 2005;191:1472-7. [PMID: 15809906 DOI: 10.1086/429634] [Cited by in Crossref: 249] [Cited by in F6Publishing: 228] [Article Influence: 14.6] [Reference Citation Analysis]
345 Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631-637. [PMID: 15141377 DOI: 10.1002/path.1570] [Cited by in Crossref: 2629] [Cited by in F6Publishing: 2460] [Article Influence: 146.1] [Reference Citation Analysis]
346 Mellema RA, Crandell J, Petrey AC. Platelet Dysregulation in the Pathobiology of COVID-19. Hamostaseologie 2021. [PMID: 34879421 DOI: 10.1055/a-1646-3392] [Reference Citation Analysis]
347 Abrahamson SD, Canzian S, Brunet F. Using simulation for training and to change protocol during the outbreak of severe acute respiratory syndrome. Crit Care 2006;10:R3. [PMID: 16356209 DOI: 10.1186/cc3916] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
348 Saijo M, Morikawa S, Fukushi S, Mizutani T, Hasegawa H, Nagata N, Iwata N, Kurane I. Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus. Antiviral Res. 2005;66:159-163. [PMID: 15911031 DOI: 10.1016/j.antiviral.2005.01.003] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
349 Ning T, Liu S, Xu J, Yang Y, Zhang N, Xie S, Min L, Zhang S, Zhu S, Wang Y. Potential intestinal infection and faecal-oral transmission of human coronaviruses. Rev Med Virol 2022;:e2363. [PMID: 35584273 DOI: 10.1002/rmv.2363] [Reference Citation Analysis]
350 Han DP, Penn-Nicholson A, Cho MW. Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor. Virology 2006;350:15-25. [PMID: 16510163 DOI: 10.1016/j.virol.2006.01.029] [Cited by in Crossref: 108] [Cited by in F6Publishing: 104] [Article Influence: 6.8] [Reference Citation Analysis]
351 To KK, Hung IF, Chan JF, Yuen KY. From SARS coronavirus to novel animal and human coronaviruses. J Thorac Dis 2013;5 Suppl 2:S103-8. [PMID: 23977429 DOI: 10.3978/j.issn.2072-1439.2013.06.02] [Cited by in F6Publishing: 37] [Reference Citation Analysis]
352 Zheng BJ, Wong KH, Zhou J, Wong KL, Young BW, Lu LW, Lee SS. SARS-related virus predating SARS outbreak, Hong Kong. Emerg Infect Dis. 2004;10:176-178. [PMID: 15030679 DOI: 10.3201/eid1002.030533] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 3.7] [Reference Citation Analysis]
353 Ogimi C, Kim YJ, Martin ET, Huh HJ, Chiu CH, Englund JA. What's New With the Old Coronaviruses? J Pediatric Infect Dis Soc 2020;9:210-7. [PMID: 32314790 DOI: 10.1093/jpids/piaa037] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
354 Nickell LA, Crighton EJ, Tracy CS, Al-Enazy H, Bolaji Y, Hanjrah S, Hussain A, Makhlouf S, Upshur RE. Psychosocial effects of SARS on hospital staff: survey of a large tertiary care institution. CMAJ 2004;170:793-8. [PMID: 14993174 DOI: 10.1503/cmaj.1031077] [Cited by in Crossref: 338] [Cited by in F6Publishing: 295] [Article Influence: 18.8] [Reference Citation Analysis]
355 Hwa KY, Lin WM, Hou YI, Yeh TM. Peptide mimicrying between SARS coronavirus spike protein and human proteins reacts with SARS patient serum. J Biomed Biotechnol 2008;2008:326464. [PMID: 18320019 DOI: 10.1155/2008/326464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
356 Subbarao K, Roberts A. Is there an ideal animal model for SARS? Trends Microbiol 2006;14:299-303. [PMID: 16759866 DOI: 10.1016/j.tim.2006.05.007] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 4.4] [Reference Citation Analysis]
357 Gillim-Ross L, Taylor J, Scholl DR, Ridenour J, Masters PS, Wentworth DE. Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR. J Clin Microbiol 2004;42:3196-206. [PMID: 15243082 DOI: 10.1128/JCM.42.7.3196-3206.2004] [Cited by in Crossref: 63] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
358 Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 2009;9:291-300. [PMID: 19393959 DOI: 10.1016/S1473-3099(09)70069-6] [Cited by in Crossref: 480] [Cited by in F6Publishing: 288] [Article Influence: 36.9] [Reference Citation Analysis]
359 Ge F, Luo Y, Liew PX, Hung E. Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening. Virology 2007;360:150-8. [PMID: 17098272 DOI: 10.1016/j.virol.2006.10.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
360 Nishiura H, Patanarapelert K, Sriprom M, Sarakorn W, Sriyab S, Ming Tang I. Modelling potential responses to severe acute respiratory syndrome in Japan: the role of initial attack size, precaution, and quarantine. J Epidemiol Community Health 2004;58:186-91. [PMID: 14966229 DOI: 10.1136/jech.2003.014894] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
361 Tsai MC, Arnold JL, Chuang CC, Chi CH, Liu CC, Yang YJ. Impact of an outbreak of severe acute respiratory syndrome on a hospital in Taiwan, ROC. Emerg Med J 2004;21:311-6. [PMID: 15107369 DOI: 10.1136/emj.2003.011122] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
362 Poon LL, Guan Y, Nicholls JM, Yuen KY, Peiris JS. The aetiology, origins, and diagnosis of severe acute respiratory syndrome. Lancet Infect Dis. 2004;4:663-671. [PMID: 15522678 DOI: 10.1016/s1473-3099(04)01172-7] [Cited by in Crossref: 111] [Cited by in F6Publishing: 84] [Article Influence: 6.2] [Reference Citation Analysis]
363 Hussell T, Snelgrove R, Humphreys IR, Williams AE. Co-stimulation: novel methods for preventing viral-induced lung inflammation. Trends Mol Med 2004;10:379-86. [PMID: 15310458 DOI: 10.1016/j.molmed.2004.06.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
364 Zou Z, Yang Y, Chen J, Xin S, Zhang W, Zhou X, Mao Y, Hu L, Liu D, Chang B, Chang W, Liu Y, Ma X, Wang Y, Liu X. Prognostic factors for severe acute respiratory syndrome: a clinical analysis of 165 cases. Clin Infect Dis 2004;38:483-9. [PMID: 14765339 DOI: 10.1086/380973] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
365 Styra R, Hawryluck L, Mc Geer A, Dimas M, Sheen J, Giacobbe P, Dattani N, Lorello G, Rac VE, Francis T, Wu PE, Luk WS, Ng E, Nadarajah J, Wingrove K, Gold WL. Surviving SARS and living through COVID-19: Healthcare worker mental health outcomes and insights for coping. PLoS One 2021;16:e0258893. [PMID: 34758047 DOI: 10.1371/journal.pone.0258893] [Reference Citation Analysis]
366 Salleras L. [Severe Acute Respiratory Syndrome. A new emergent infectious disease]. Med Clin (Barc) 2003;120:619-21. [PMID: 12732127 DOI: 10.1016/s0025-7753(03)73789-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
367 Patrick DM, Petric M, Skowronski DM, Guasparini R, Booth TF, Krajden M, McGeer P, Bastien N, Gustafson L, Dubord J, Macdonald D, David ST, Srour LF, Parker R, Andonov A, Isaac-Renton J, Loewen N, McNabb G, McNabb A, Goh SH, Henwick S, Astell C, Guo JP, Drebot M, Tellier R, Plummer F, Brunham RC. An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus. Can J Infect Dis Med Microbiol 2006;17:330-6. [PMID: 18382647 DOI: 10.1155/2006/152612] [Cited by in Crossref: 94] [Cited by in F6Publishing: 84] [Article Influence: 8.5] [Reference Citation Analysis]
368 Singh K, Hsu LY, Villacian JS, Habib A, Fisher D, Tambyah PA. Severe acute respiratory syndrome: lessons from Singapore. Emerg Infect Dis 2003;9:1294-8. [PMID: 14609466 DOI: 10.3201/eid0910.030388] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
369 Bressler AM, Nolte FS. Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirus. J Clin Microbiol 2004;42:987-91. [PMID: 15004042 DOI: 10.1128/JCM.42.3.987-991.2004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
370 Khalili JS, Zhu H, Mak NSA, Yan Y, Zhu Y. Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19. J Med Virol 2020;92:740-6. [PMID: 32227493 DOI: 10.1002/jmv.25798] [Cited by in Crossref: 132] [Cited by in F6Publishing: 112] [Article Influence: 66.0] [Reference Citation Analysis]
371 Zhong NS, Zheng BJ, Li YM, Poon, Xie ZH, Chan KH, Li PH, Tan SY, Chang Q, Xie JP, Liu XQ, Xu J, Li DX, Yuen KY, Peiris, Guan Y. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet. 2003;362:1353-1358. [PMID: 14585636 DOI: 10.1016/s0140-6736(03)14630-2] [Cited by in Crossref: 745] [Cited by in F6Publishing: 493] [Article Influence: 41.4] [Reference Citation Analysis]
372 Liu X, Zhang M, He L, Li Y. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). Cochrane Database Syst Rev 2012;10:CD004882. [PMID: 23076910 DOI: 10.1002/14651858.CD004882.pub3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
373 Hsueh PR, Hsiao CH, Yeh SH, Wang WK, Chen PJ, Wang JT, Chang SC, Kao CL, Yang PC; SARS Research Group of National Taiwan University College of Medicine and National Taiwan University Hospital. Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg Infect Dis 2003;9:1163-7. [PMID: 14519257 DOI: 10.3201/eid0909.030367] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 2.8] [Reference Citation Analysis]
374 Esper F, Martinello RA, Boucher D, Weibel C, Ferguson D, Landry ML, Kahn JS. A 1-year experience with human metapneumovirus in children aged <5 years. J Infect Dis 2004;189:1388-96. [PMID: 15073675 DOI: 10.1086/382482] [Cited by in Crossref: 156] [Cited by in F6Publishing: 143] [Article Influence: 8.7] [Reference Citation Analysis]
375 Tan EL, Ooi EE, Lin CY, Tan HC, Ling AE, Lim B, Stanton LW. Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Emerg Infect Dis. 2004;10:581-586. [PMID: 15200845 DOI: 10.3201/eid1004.030458] [Cited by in Crossref: 154] [Cited by in F6Publishing: 144] [Article Influence: 8.6] [Reference Citation Analysis]
376 Mackenzie JS. Responding to emerging diseases: reducing the risks through understanding the mechanisms of emergence. Western Pac Surveill Response J 2011;2:1-5. [PMID: 23908876 DOI: 10.2471/WPSAR.2011.2.1.006] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
377 Tripp RA, Haynes LM, Moore D, Anderson B, Tamin A, Harcourt BH, Jones LP, Yilla M, Babcock GJ, Greenough T, Ambrosino DM, Alvarez R, Callaway J, Cavitt S, Kamrud K, Alterson H, Smith J, Harcourt JL, Miao C, Razdan R, Comer JA, Rollin PE, Ksiazek TG, Sanchez A, Rota PA, Bellini WJ, Anderson LJ. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. J Virol Methods 2005;128:21-8. [PMID: 15885812 DOI: 10.1016/j.jviromet.2005.03.021] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
378 Mazzoncini JP Jr, Crowell CB, Kang CS. Human metapneumovirus: an emerging respiratory pathogen. J Emerg Med 2010;38:456-9. [PMID: 18584996 DOI: 10.1016/j.jemermed.2007.11.051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
379 Wong ACP, Lau SKP, Woo PCY. Interspecies Jumping of Bat Coronaviruses. Viruses 2021;13:2188. [PMID: 34834994 DOI: 10.3390/v13112188] [Reference Citation Analysis]
380 Hecht LS, Jurado-Jimenez A, Hess M, Halas HE, Bochenek G, Mohammed H, Alzahrani F, Asiri MO, Hasan R, Alamri A, Alotaibi S. Verification and diagnostic evaluation of the RealStar® Middle East respiratory syndrome coronavirus (N gene) reverse transcription-PCR kit 1.0. Future Microbiol 2019;14:941-8. [PMID: 31271059 DOI: 10.2217/fmb-2019-0067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
381 Xu Y, Lou Z, Liu Y, Pang H, Tien P, Gao GF, Rao Z. Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core. J Biol Chem 2004;279:49414-9. [PMID: 15345712 DOI: 10.1074/jbc.M408782200] [Cited by in Crossref: 145] [Cited by in F6Publishing: 120] [Article Influence: 8.1] [Reference Citation Analysis]
382 Donnelly CA, Fisher MC, Fraser C, Ghani AC, Riley S, Ferguson NM, Anderson RM. Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infect Dis 2004;4:672-83. [PMID: 15522679 DOI: 10.1016/S1473-3099(04)01173-9] [Cited by in Crossref: 72] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
383 Chang SM, Liu CL, Kuo HT, Chen PJ, Lee CM, Lin FJ, Lin CC, Lee CH, Lu YT. Comparative study of patients with and without SARS who fulfilled the WHO SARS case definition. J Emerg Med 2005;28:395-402. [PMID: 15837019 DOI: 10.1016/j.jemermed.2004.11.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
384 Chan HLY, Kwan ACP, To KF, Lai ST, Chan PKS, Leung WK, Lee N, Wu A, Sung JJY. Clinical significance of hepatic derangement in severe acute respiratory syndrome. World J Gastroenterol 2005; 11(14): 2148-2153 [PMID: 15810082 DOI: 10.3748/wjg.v11.i14.2148] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
385 Liu IJ, Hsueh PR, Lin CT, Chiu CY, Kao CL, Liao MY, Wu HC. Disease-specific B Cell epitopes for serum antibodies from patients with severe acute respiratory syndrome (SARS) and serologic detection of SARS antibodies by epitope-based peptide antigens. J Infect Dis 2004;190:797-809. [PMID: 15272409 DOI: 10.1086/422753] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
386 Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res 2011;81:85-164. [PMID: 22094080 DOI: 10.1016/B978-0-12-385885-6.00009-2] [Cited by in Crossref: 468] [Cited by in F6Publishing: 293] [Article Influence: 46.8] [Reference Citation Analysis]
387 Cheng VC, Tang BS, Wu AK, Chu CM, Yuen KY. Medical treatment of viral pneumonia including SARS in immunocompetent adult. J Infect. 2004;49:262-273. [PMID: 15474623 DOI: 10.1016/j.jinf.2004.07.010] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 3.7] [Reference Citation Analysis]
388 Alathari MJA, Al Mashhadany Y, Mokhtar MHH, Burham N, Bin Zan MSD, A Bakar AA, Arsad N. Human Body Performance with COVID-19 Affectation According to Virus Specification Based on Biosensor Techniques. Sensors (Basel) 2021;21:8362. [PMID: 34960456 DOI: 10.3390/s21248362] [Reference Citation Analysis]
389 Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MUG, Khan K. Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. J Travel Med. 2020;27. [PMID: 31943059 DOI: 10.1093/jtm/taaa008] [Cited by in Crossref: 306] [Cited by in F6Publishing: 234] [Article Influence: 153.0] [Reference Citation Analysis]
390 Jia HP, Look DC, Hickey M, Shi L, Pewe L, Netland J, Farzan M, Wohlford-Lenane C, Perlman S, McCray PB Jr. Infection of human airway epithelia by SARS coronavirus is associated with ACE2 expression and localization. Adv Exp Med Biol 2006;581:479-84. [PMID: 17037581 DOI: 10.1007/978-0-387-33012-9_85] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
391 Chen L, Gui C, Luo X, Yang Q, Günther S, Scandella E, Drosten C, Bai D, He X, Ludewig B, Chen J, Luo H, Yang Y, Yang Y, Zou J, Thiel V, Chen K, Shen J, Shen X, Jiang H. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol 2005;79:7095-103. [PMID: 15890949 DOI: 10.1128/JVI.79.11.7095-7103.2005] [Cited by in Crossref: 116] [Cited by in F6Publishing: 92] [Article Influence: 6.8] [Reference Citation Analysis]
392 Allen U, Hébert D, Churchill C, Read S, Bitnun A, Richardson S, Matlow A, Tellier R, Goldman C, Wray R, King S, Opavsky MA, Ford-Jones E, Hernandez M, Kitai I; SARS Investigative and Management Teams Relevant to Transplantation. The potential impact of SARS on organ transplantation: exercise caution. Pediatr Transplant 2003;7:345-7. [PMID: 14738293 DOI: 10.1034/j.1399-3046.2003.00104.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
393 Ito N, Mossel EC, Narayanan K, Popov VL, Huang C, Inoue T, Peters CJ, Makino S. Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein. J Virol 2005;79:3182-6. [PMID: 15709039 DOI: 10.1128/JVI.79.5.3182-3186.2005] [Cited by in Crossref: 93] [Cited by in F6Publishing: 77] [Article Influence: 5.5] [Reference Citation Analysis]
394 Chen RF, Chang JC, Yeh WT, Lee CH, Liu JW, Eng HL, Yang KD. Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS). Microbes Infect 2006;8:122-7. [PMID: 16182592 DOI: 10.1016/j.micinf.2005.06.007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
395 Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C; Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37:1405-33. [PMID: 14614663 DOI: 10.1086/380488] [Cited by in Crossref: 740] [Cited by in F6Publishing: 558] [Article Influence: 38.9] [Reference Citation Analysis]
396 Groneberg DA, Zhang L, Welte T, Zabel P, Chung KF. Severe acute respiratory syndrome: global initiatives for disease diagnosis. QJM 2003;96:845-52. [PMID: 14566040 DOI: 10.1093/qjmed/hcg146] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
397 Babyn PS, Chu WC, Tsou IY, Wansaicheong GK, Allen U, Bitnun A, Chee TS, Cheng FW, Chiu MC, Fok TF, Hon EK, Gahunia HK, Kaw GJ, Khong PL, Leung CW, Li AM, Manson D, Metreweli C, Ng PC, Read S, Stringer DA. Severe acute respiratory syndrome (SARS): chest radiographic features in children. Pediatr Radiol 2004;34:47-58. [PMID: 14624321 DOI: 10.1007/s00247-003-1081-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
398 Nascimento GC, Santos GM, Moura SRB, de Carvalho ARB, da Silva Andrade L, Moura LKB, Mendes F, Moreira MASP, Moura MEB. Bibliometric Analysis Of Research on Coronavirus Infection and Patient Safety in Health Care. TONURSJ 2021;15:373-9. [DOI: 10.2174/1874434602115010373] [Reference Citation Analysis]
399 Xu X, Liu Y, Weiss S, Arnold E, Sarafianos SG, Ding J. Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design. Nucleic Acids Res 2003;31:7117-30. [PMID: 14654687 DOI: 10.1093/nar/gkg916] [Cited by in Crossref: 115] [Cited by in F6Publishing: 117] [Article Influence: 6.4] [Reference Citation Analysis]
400 Draker R, Roper RL, Petric M, Tellier R. The complete sequence of the bovine torovirus genome. Virus Res 2006;115:56-68. [PMID: 16137782 DOI: 10.1016/j.virusres.2005.07.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
401 Cibrelus L, Nöel V, Emmanuelli J, Breton G, Longuet P, Rigolli B, Leport C, Vildé JL. [Management of 90 patients presenting with suspected severe acute respiratory syndrome. Experience of a collaboration between epidemiologists and clinicians facing an emerging infectious disease health alert]. Med Mal Infect 2007;37 Suppl 3:S242-50. [PMID: 17997252 DOI: 10.1016/j.medmal.2006.03.006] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
402 Schrag SJ, Brooks JT, Van Beneden C, Parashar UD, Griffin PM, Anderson LJ, Bellini WJ, Benson RF, Erdman DD, Klimov A, Ksiazek TG, Peret TC, Talkington DF, Thacker WL, Tondella ML, Sampson JS, Hightower AW, Nordenberg DF, Plikaytis BD, Khan AS, Rosenstein NE, Treadwell TA, Whitney CG, Fiore AE, Durant TM, Perz JF, Wasley A, Feikin D, Herndon JL, Bower WA, Klibourn BW, Levy DA, Coronado VG, Buffington J, Dykewicz CA, Khabbaz RF, Chamberland ME. SARS surveillance during emergency public health response, United States, March-July 2003. Emerg Infect Dis 2004;10:185-94. [PMID: 15030681 DOI: 10.3201/eid1002.030752] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
403 Huang HH, Yen DH, Kao WF, Wang LM, Huang CI, Lee CH. Declining emergency department visits and costs during the severe acute respiratory syndrome (SARS) outbreak. J Formos Med Assoc 2006;105:31-7. [PMID: 16440068 DOI: 10.1016/S0929-6646(09)60106-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
404 Gillim-Ross L, Subbarao K. Emerging respiratory viruses: challenges and vaccine strategies. Clin Microbiol Rev 2006;19:614-36. [PMID: 17041137 DOI: 10.1128/CMR.00005-06] [Cited by in Crossref: 105] [Cited by in F6Publishing: 59] [Article Influence: 6.6] [Reference Citation Analysis]
405 Hsu CH, Hwang KC, Chao CL, Chang SG, Ho MS, Lin JG, Chang HH, Kao ST, Chen YM, Chou P. An Evaluation of the Additive Effect of Natural Herbal Medicine on SARS or SARS-like Infectious Diseases in 2003: A Randomized, Double-blind, and Controlled Pilot Study. Evid Based Complement Alternat Med 2008;5:355-62. [PMID: 18830453 DOI: 10.1093/ecam/nem035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
406 Henrina J, Putra ICS, Lawrensia S, Handoyono QF, Cahyadi A. Coronavirus Disease of 2019: a Mimicker of Dengue Infection? SN Compr Clin Med 2020;:1-11. [PMID: 32838165 DOI: 10.1007/s42399-020-00364-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
407 Wang XW, Li JS, Guo TK, Zhen B, Kong QX, Yi B, Li Z, Song N, Jin M, Xiao WJ, Zhu XM, Gu CQ, Yin J, Wei W, Yao W, Liu C, Li JF, Ou GR, Wang MN, Fang TY, Wang GJ, Qiu YH, Wu HH, Chao FH, Li JW. Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th Hospital. J Virol Methods 2005;128:156-61. [PMID: 15964082 DOI: 10.1016/j.jviromet.2005.03.022] [Cited by in Crossref: 84] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
408 Kamitani W, Narayanan K, Huang C, Lokugamage K, Ikegami T, Ito N, Kubo H, Makino S. Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc Natl Acad Sci USA. 2006;103:12885-12890. [PMID: 16912115 DOI: 10.1073/pnas.0603144103] [Cited by in Crossref: 259] [Cited by in F6Publishing: 244] [Article Influence: 16.2] [Reference Citation Analysis]
409 Sharma S, Jeyaraman M, Muthu S, Anudeep TC, Jeyaraman N, Shringeri AS, Kumar V, Somasundaram R, Jain R, Jha SK. A Step Toward Optimizing Regenerative Medicine Principle to Combat COVID-19. Ann Natl Acad Med Sci 2021;57:202-13. [DOI: 10.1055/s-0041-1731597] [Reference Citation Analysis]
410 Cho KS, Yoon J. Fever Screening and Detection of Febrile Arrivals at an International Airport in Korea: Association among Self-reported Fever, Infrared Thermal Camera Scanning, and Tympanic Temperature. Epidemiol Health 2014;36:e2014004. [PMID: 25045577 DOI: 10.4178/epih/e2014004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
411 Ooi SB, Tambyah PA. Transmission of severe acute respiratory syndrome in an emergency department. Am J Med 2004;116:486-9. [PMID: 15047039 DOI: 10.1016/j.amjmed.2003.11.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
412 Wong RS, Wu A, To KF, Lee N, Lam CW, Wong CK, Chan PK, Ng MH, Yu LM, Hui DS, Tam JS, Cheng G, Sung JJ. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003;326:1358-62. [PMID: 12816821 DOI: 10.1136/bmj.326.7403.1358] [Cited by in Crossref: 350] [Cited by in F6Publishing: 341] [Article Influence: 18.4] [Reference Citation Analysis]
413 Marsden PA, Ning Q, Fung LS, Luo X, Chen Y, Mendicino M, Ghanekar A, Scott JA, Miller T, Chan CW. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest. 2003;112:58-66. [PMID: 12840059 DOI: 10.1172/jci200318114] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
414 Kumar D, Tellier R, Draker R, Levy G, Humar A. Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant. 2003;3:977-981. [PMID: 12859532 DOI: 10.1034/j.1600-6143.2003.00197.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 98] [Article Influence: 6.3] [Reference Citation Analysis]
415 Suresh MR, Bhatnagar PK, Das D. Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV). J Pharm Pharm Sci 2008;11:1s-13s. [PMID: 19203466 DOI: 10.18433/j3j019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
416 Tsao KC, Chen GW, Huang CG, Huang YL, Lin JY, Mok CK, Sun CF, Shih SR. False positive antibody results against human T-cell lymphotropic virus in patients with severe acute respiratory syndrome. J Med Virol 2005;77:331-6. [PMID: 16173022 DOI: 10.1002/jmv.20460] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
417 He Q, Chong KH, Chng HH, Leung B, Ling AE, Wei T, Chan SW, Ooi EE, Kwang J. Development of a Western blot assay for detection of antibodies against coronavirus causing severe acute respiratory syndrome. Clin Diagn Lab Immunol 2004;11:417-22. [PMID: 15013997 DOI: 10.1128/cdli.11.2.417-422.2004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
418 Nitsche A, Schweiger B, Ellerbrok H, Niedrig M, Pauli G. SARS coronavirus detection. Emerg Infect Dis 2004;10:1300-3. [PMID: 15324554 DOI: 10.3201/eid1007.030678] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
419 Céspedes PF, Palavecino CE, Kalergis AM, Bueno SM. Modulation of Host Immunity by the Human Metapneumovirus. Clin Microbiol Rev 2016;29:795-818. [PMID: 27413096 DOI: 10.1128/CMR.00081-15] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 4.2] [Reference Citation Analysis]
420 Wang CH, Liu CY, Wan YL, Chou CL, Huang KH, Lin HC, Lin SM, Lin TY, Chung KF, Kuo HP. Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS. Respir Res 2005;6:42. [PMID: 15888207 DOI: 10.1186/1465-9921-6-42] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 2.8] [Reference Citation Analysis]
421 Rodrigues PB, Dos Santos Pereira Gomes AB, Genaro LM, Pascoal LB, de Souza APD, Leal RF, Vinolo MAR. Intestinal Microbiota in the SARS-CoV-2 Infection: What Is Known? Adv Exp Med Biol 2021;1327:93-106. [PMID: 34279831 DOI: 10.1007/978-3-030-71697-4_7] [Reference Citation Analysis]
422 Tse GM, To KF, Chan PK, Lo AW, Ng KC, Wu A, Lee N, Wong HC, Mak SM, Chan KF, Hui DS, Sung JJ, Ng HK. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). J Clin Pathol 2004;57:260-5. [PMID: 14990596 DOI: 10.1136/jcp.2003.013276] [Cited by in Crossref: 144] [Cited by in F6Publishing: 136] [Article Influence: 8.0] [Reference Citation Analysis]
423 Boutis K, Stephens D, Lam K, Ungar WJ, Schuh S. The impact of SARS on a tertiary care pediatric emergency department. CMAJ 2004;171:1353-8. [PMID: 15557588 DOI: 10.1503/cmaj.1031257] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
424 Lazar I, Weibel C, Dziura J, Ferguson D, Landry ML, Kahn JS. Human metapneumovirus and severity of respiratory syncytial virus disease. Emerg Infect Dis 2004;10:1318-20. [PMID: 15324559 DOI: 10.3201/eid1007.030983] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
425 Khattari Z, Arbely E, Arkin IT, Salditt T. Viral ion channel proteins in model membranes: a comparative study by X-ray reflectivity. Eur Biophys J 2006;36:45-55. [PMID: 17019591 DOI: 10.1007/s00249-006-0099-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
426 Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res 2011;81:85-164. [PMID: 22094080 DOI: 10.1016/B978-0-12-385885-6.00009-2] [Cited by in Crossref: 426] [Cited by in F6Publishing: 1] [Article Influence: 38.7] [Reference Citation Analysis]
427 He Y, Zhou Y, Siddiqui P, Niu J, Jiang S. Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol 2005;43:3718-26. [PMID: 16081901 DOI: 10.1128/JCM.43.8.3718-3726.2005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
428 Knudsen TB, Kledal TN, Andersen O, Eugen-Olsen J, Kristiansen TB. Severe acute respiratory syndrome--a new coronavirus from the Chinese dragon's lair. Scand J Immunol 2003;58:277-84. [PMID: 12950672 DOI: 10.1046/j.1365-3083.2003.01302.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
429 Chau TN, Lee PO, Choi KW, Lee CM, Ma KF, Tsang TY, Tso YK, Chiu MC, Tong WL, Yu WC, Lai ST. Value of initial chest radiographs for predicting clinical outcomes in patients with severe acute respiratory syndrome. Am J Med 2004;117:249-54. [PMID: 15308434 DOI: 10.1016/j.amjmed.2004.03.020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
430 Brunet FP; FRCPC. [Consequences of the SARS outbreak on the Health Care System in Ontario]. Reanimation 2007;16:245-9. [PMID: 32362807 DOI: 10.1016/j.reaurg.2007.02.017] [Reference Citation Analysis]
431 Radigan KA, Wunderink RG. Epidemic viral pneumonia and other emerging pathogens. Clin Chest Med 2011;32:451-67. [PMID: 21867815 DOI: 10.1016/j.ccm.2011.05.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
432 Mack TM. The ghost of pandemics past. Lancet 2005;365:1370-2. [PMID: 15836872 DOI: 10.1016/S0140-6736(05)66352-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
433 Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet 2010;376:1339-46. [PMID: 20934212 DOI: 10.1016/S0140-6736(10)60446-1] [Cited by in Crossref: 591] [Cited by in F6Publishing: 289] [Article Influence: 49.3] [Reference Citation Analysis]
434 Mahony JB, Richardson S. Molecular diagnosis of severe acute respiratory syndrome: the state of the art. J Mol Diagn 2005;7:551-9. [PMID: 16258152 DOI: 10.1016/S1525-1578(10)60587-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
435 Khanolkar A, Hartwig SM, Haag BA, Meyerholz DK, Harty JT, Varga SM. Toll-like receptor 4 deficiency increases disease and mortality after mouse hepatitis virus type 1 infection of susceptible C3H mice. J Virol 2009;83:8946-56. [PMID: 19553337 DOI: 10.1128/JVI.01857-08] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
436 Lee N, Chan PK, Yu IT, Tsoi KK, Lui G, Sung JJ, Cockram CS. Co-circulation of human metapneumovirus and SARS-associated coronavirus during a major nosocomial SARS outbreak in Hong Kong. J Clin Virol 2007;40:333-7. [PMID: 17936066 DOI: 10.1016/j.jcv.2007.08.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
437 Debiaggi M, Canducci F, Ceresola ER, Clementi M. The role of infections and coinfections with newly identified and emerging respiratory viruses in children. Virol J 2012;9:247. [PMID: 23102237 DOI: 10.1186/1743-422X-9-247] [Cited by in Crossref: 76] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
438 Xing W, Hejblum G, Leung GM, Valleron AJ. Anatomy of the epidemiological literature on the 2003 SARS outbreaks in Hong Kong and Toronto: a time-stratified review. PLoS Med 2010;7:e1000272. [PMID: 20454570 DOI: 10.1371/journal.pmed.1000272] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
439 Prentice E, Jerome WG, Yoshimori T, Mizushima N, Denison MR. Coronavirus replication complex formation utilizes components of cellular autophagy. J Biol Chem. 2004;279:10136-10141. [PMID: 14699140 DOI: 10.1074/jbc.m306124200] [Cited by in Crossref: 280] [Cited by in F6Publishing: 235] [Article Influence: 14.7] [Reference Citation Analysis]
440 Lai KN, Tsang KW, Seto WH, Ooi CG. Clinical, Laboratory, and Radiologic Manifestation of SARS. Curr Infect Dis Rep 2004;6:213-9. [PMID: 15142485 DOI: 10.1007/s11908-004-0011-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
441 Cavanagh D. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathol. 2003;32:567-582. [PMID: 14676007 DOI: 10.1080/03079450310001621198] [Cited by in Crossref: 208] [Cited by in F6Publishing: 186] [Article Influence: 11.6] [Reference Citation Analysis]
442 Savedchuk S, Raslan R, Nystrom S, Sparks MA. Emerging Viral Infections and the Potential Impact on Hypertension, Cardiovascular Disease, and Kidney Disease. Circ Res 2022;130:1618-41. [PMID: 35549373 DOI: 10.1161/CIRCRESAHA.122.320873] [Reference Citation Analysis]
443 Hamelin ME, Abed Y, Boivin G. Human metapneumovirus: a new player among respiratory viruses. Clin Infect Dis 2004;38:983-90. [PMID: 15034830 DOI: 10.1086/382536] [Cited by in Crossref: 130] [Cited by in F6Publishing: 112] [Article Influence: 7.2] [Reference Citation Analysis]
444 Ngondiep E. A robust numerical two-level second-order explicit approach to predicting the spread of Covid-2019 pandemic with undetected infectious cases. J Comput Appl Math 2022;403:113852. [PMID: 34629699 DOI: 10.1016/j.cam.2021.113852] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
445 Jin Y, Lei C, Hu D, Dimitrov DS, Ying T. Human monoclonal antibodies as candidate therapeutics against emerging viruses. Front Med 2017;11:462-70. [PMID: 29159596 DOI: 10.1007/s11684-017-0596-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
446 Gumel AB, Ruan S, Day T, Watmough J, Brauer F, van den Driessche P, Gabrielson D, Bowman C, Alexander ME, Ardal S, Wu J, Sahai BM. Modelling strategies for controlling SARS outbreaks. Proc Biol Sci 2004;271:2223-32. [PMID: 15539347 DOI: 10.1098/rspb.2004.2800] [Cited by in Crossref: 197] [Cited by in F6Publishing: 129] [Article Influence: 11.6] [Reference Citation Analysis]
447 Haagmans BL, Kuiken T, Martina BE, Fouchier RA, Rimmelzwaan GF, van Amerongen G, van Riel D, de Jong T, Itamura S, Chan KH, Tashiro M, Osterhaus AD. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med. 2004;10:290-293. [PMID: 14981511 DOI: 10.1038/nm1001] [Cited by in Crossref: 285] [Cited by in F6Publishing: 262] [Article Influence: 15.8] [Reference Citation Analysis]
448 Zhang JZ. Severe acute respiratory syndrome and its lesions in digestive system. World J Gastroenterol 2003; 9(6): 1135-1138 [PMID: 12800212 DOI: 10.3748/wjg.v9.i6.1135] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
449 Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res 2020;7:11. [PMID: 32169119 DOI: 10.1186/s40779-020-00240-0] [Cited by in Crossref: 1097] [Cited by in F6Publishing: 1253] [Article Influence: 548.5] [Reference Citation Analysis]
450 Kamming D, Gardam M, Chung F. Anaesthesia and SARS. Br J Anaesth. 2003;90:715-718. [PMID: 12765882 DOI: 10.1093/bja/aeg173] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 3.7] [Reference Citation Analysis]
451 Luo C, Luo H, Zheng S, Gui C, Yue L, Yu C, Sun T, He P, Chen J, Shen J, Luo X, Li Y, Liu H, Bai D, Shen J, Yang Y, Li F, Zuo J, Hilgenfeld R, Pei G, Chen K, Shen X, Jiang H. Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A. Biochem Biophys Res Commun 2004;321:557-65. [PMID: 15358143 DOI: 10.1016/j.bbrc.2004.07.003] [Cited by in Crossref: 79] [Cited by in F6Publishing: 76] [Article Influence: 4.4] [Reference Citation Analysis]
452 Chan PK, Ip M, Ng KC, Rickjason CW, Wu A, Lee N, Rainer TH, Joynt GM, Sung JJ, Tam JS. Severe acute respiratory syndrome-associated coronavirus infection. Emerg Infect Dis 2003;9:1453-4. [PMID: 14718090 DOI: 10.3201/eid0911.030421] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
453 Alfaro E, Díaz-garcía E, García-tovar S, Zamarrón E, Mangas A, Galera R, López-collazo E, García-rio F, Cubillos-zapata C. Upregulated Proteasome Subunits in COVID-19 Patients: A Link with Hypoxemia, Lymphopenia and Inflammation. Biomolecules 2022;12:442. [DOI: 10.3390/biom12030442] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
454 Stark CJ, Atreya CD. Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies. Virol J 2005;2:35. [PMID: 15833113 DOI: 10.1186/1743-422X-2-35] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
455 Tang HL, Cheuk A, Chu KH, Lee W, Wong SH, Cheng YL, Yu AW, Fung KS, Tsang WK, Chan HW, Tong KL. Severe acute respiratory syndrome in haemodialysis patients: a report of two cases. Nephrol Dial Transplant 2003;18:2178-81. [PMID: 13679500 DOI: 10.1093/ndt/gfg454] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
456 Hu T, Liu Y, Zhao M, Zhuang Q, Xu L, He Q. A comparison of COVID-19, SARS and MERS. PeerJ 2020;8:e9725. [PMID: 32879801 DOI: 10.7717/peerj.9725] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
457 Li T, Xie J, He Y, Fan H, Baril L, Qiu Z, Han Y, Xu W, Zhang W, You H, Zuo Y, Fang Q, Yu J, Chen Z, Zhang L. Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirus. PLoS One 2006;1:e24. [PMID: 17183651 DOI: 10.1371/journal.pone.0000024] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
458 Chin TW, Chant C, Tanzini R, Wells J. Severe acute respiratory syndrome (SARS): the pharmacist's role. Pharmacotherapy 2004;24:705-12. [PMID: 15222659 DOI: 10.1592/phco.24.8.705.36063] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
459 He Y, Zhou Y, Wu H, Kou Z, Liu S, Jiang S. Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus. J Clin Microbiol 2004;42:5309-14. [PMID: 15528730 DOI: 10.1128/JCM.42.11.5309-5314.2004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
460 Lai ST. Treatment of severe acute respiratory syndrome. Eur J Clin Microbiol Infect Dis. 2005;24:583-591. [PMID: 16172857 DOI: 10.1007/s10096-005-0004-z] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 3.8] [Reference Citation Analysis]
461 Tsou IY, Loh LE, Kaw GJ, Chan I, Chee TS. Severe acute respiratory syndrome (SARS) in a paediatric cluster in Singapore. Pediatr Radiol 2004;34:43-6. [PMID: 12928757 DOI: 10.1007/s00247-003-1042-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
462 Bai B, Lu X, Meng J, Hu Q, Mao P, Lu B, Chen Z, Yuan Z, Wang H. Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses. Mol Immunol 2008;45:868-75. [PMID: 17905435 DOI: 10.1016/j.molimm.2007.08.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
463 Magiorkinis G, Magiorkinis E, Paraskevis D, Vandamme AM, Van Ranst M, Moulton V, Hatzakis A. Phylogenetic analysis of the full-length SARS-CoV sequences: evidence for phylogenetic discordance in three genomic regions. J Med Virol 2004;74:369-72. [PMID: 15368527 DOI: 10.1002/jmv.20187] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
464 Xu RH, He JF, Evans MR, Peng GW, Field HE, Yu DW, Lee CK, Luo HM, Lin WS, Lin P, Li LH, Liang WJ, Lin JY, Schnur A. Epidemiologic clues to SARS origin in China. Emerg Infect Dis 2004;10:1030-7. [PMID: 15207054 DOI: 10.3201/eid1006.030852] [Cited by in Crossref: 145] [Cited by in F6Publishing: 120] [Article Influence: 8.1] [Reference Citation Analysis]
465 Rezvani M, Koren G. Pregnancy outcome after exposure to injectable ribavirin during embryogenesis. Reprod Toxicol. 2006;21:113-115. [PMID: 16122903 DOI: 10.1016/j.reprotox.2005.06.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
466 Wang BX, Fish EN. The yin and yang of viruses and interferons. Trends Immunol 2012;33:190-7. [PMID: 22321608 DOI: 10.1016/j.it.2012.01.004] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 7.9] [Reference Citation Analysis]
467 Ullah M, Wahab A, Saeed S, Khan SU, Ali H, Humayun S, Abbasi BA, Saud S, Naveed K, Khan SA, Fahad S. Coronavirus and its terrifying inning around the globe: The pharmaceutical cares at the main frontline. Chemosphere 2021;275:129968. [PMID: 33652275 DOI: 10.1016/j.chemosphere.2021.129968] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
468 Tang JW, Chan RCW. Severe acute respiratory syndrome (SARS) in intensive care units (ICUs): limiting the risk to healthcare workers. Curr Anaesth Crit Care 2004;15:143-55. [PMID: 32288321 DOI: 10.1016/j.cacc.2004.05.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
469 Hussell T, Williams A. Ménage à trois of bacterial and viral pulmonary pathogens delivers coup de grace to the lung. Clin Exp Immunol 2004;137:8-11. [PMID: 15196237 DOI: 10.1111/j.1365-2249.2004.02526.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
470 Nava S, Hill N. Non-invasive ventilation in acute respiratory failure. Lancet 2009;374:250-9. [PMID: 19616722 DOI: 10.1016/S0140-6736(09)60496-7] [Cited by in Crossref: 374] [Cited by in F6Publishing: 111] [Article Influence: 28.8] [Reference Citation Analysis]
471 Hong TC, Mai QL, Cuong DV, Parida M, Minekawa H, Notomi T, Hasebe F, Morita K. Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus. J Clin Microbiol 2004;42:1956-61. [PMID: 15131154 DOI: 10.1128/JCM.42.5.1956-1961.2004] [Cited by in Crossref: 265] [Cited by in F6Publishing: 156] [Article Influence: 14.7] [Reference Citation Analysis]
472 Wang S, Guo F, Liu K, Wang H, Rao S, Yang P, Jiang C. Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2. Virus Res 2008;136:8-15. [PMID: 18554741 DOI: 10.1016/j.virusres.2008.03.004] [Cited by in F6Publishing: 74] [Reference Citation Analysis]
473 Mallick B, Ghosh Z, Chakrabarti J. MicroRNome analysis unravels the molecular basis of SARS infection in bronchoalveolar stem cells. PLoS One 2009;4:e7837. [PMID: 19915717 DOI: 10.1371/journal.pone.0007837] [Cited by in Crossref: 80] [Cited by in F6Publishing: 68] [Article Influence: 6.2] [Reference Citation Analysis]
474 Ma J, Earn DJ. Generality of the final size formula for an epidemic of a newly invading infectious disease. Bull Math Biol 2006;68:679-702. [PMID: 16794950 DOI: 10.1007/s11538-005-9047-7] [Cited by in Crossref: 150] [Cited by in F6Publishing: 110] [Article Influence: 9.4] [Reference Citation Analysis]
475 Zhang B, Zhang J, Chen H, Chen L, Chen Q, Li M, Chen Z, You J, Yang K, Zhang S. Novel coronavirus disease 2019 (COVID-19): relationship between chest CT scores and laboratory parameters. Eur J Nucl Med Mol Imaging 2020;47:2083-9. [PMID: 32399620 DOI: 10.1007/s00259-020-04854-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
476 Lau EH, Cowling BJ, Muller MP, Ho LM, Tsang T, Lo SV, Louie M, Leung GM. Effectiveness of ribavirin and corticosteroids for severe acute respiratory syndrome. Am J Med 2009; 122: 1150.e11-1150. e21. [PMID: 19958895 DOI: 10.1016/j.amjmed.2009.07.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
477 Cheng VC, Lau SK, Woo PC, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev. 2007;20:660-694. [PMID: 17934078 DOI: 10.1128/cmr.00023-07] [Cited by in Crossref: 543] [Cited by in F6Publishing: 342] [Article Influence: 36.2] [Reference Citation Analysis]
478 Saijo M, Ogino T, Taguchi F, Fukushi S, Mizutani T, Notomi T, Kanda H, Minekawa H, Matsuyama S, Long HT, Hanh NT, Kurane I, Tashiro M, Morikawa S. Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS. J Virol Methods 2005;125:181-6. [PMID: 15794988 DOI: 10.1016/j.jviromet.2005.01.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
479 Lin YS, Lin CF, Fang YT, Kuo YM, Liao PC, Yeh TM, Hwa KY, Shieh CC, Yen JH, Wang HJ, Su IJ, Lei HY. Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity. Clin Exp Immunol 2005;141:500-8. [PMID: 16045740 DOI: 10.1111/j.1365-2249.2005.02864.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
480 Farquharson C, Baguley K. Responding to the severe acute respiratory syndrome (SARS) outbreak: lessons learned in a Toronto emergency department. J Emerg Nurs 2003;29:222-8. [PMID: 12776077 DOI: 10.1067/men.2003.109] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
481 Ariani F, Liu K, Jing Z, Qu J. Glucocorticosteroid in treatment of severe pneumonia. Mediators Inflamm 2013;2013:865635. [PMID: 24363503 DOI: 10.1155/2013/865635] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
482 Ng EK, Lo YM. Molecular diagnosis of severe acute respiratory syndrome. Methods Mol Biol 2006;336:163-75. [PMID: 16916262 DOI: 10.1385/1-59745-074-X:163] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
483 Ma XZ, Bartczak A, Zhang J, Khattar R, Chen L, Liu MF, Edwards A, Levy G, McGilvray ID. Proteasome inhibition in vivo promotes survival in a lethal murine model of severe acute respiratory syndrome. J Virol 2010;84:12419-28. [PMID: 20861244 DOI: 10.1128/JVI.01219-10] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
484 Wang TL, Jang TN, Huang CH, Kao SJ, Lin CM, Lee FN, Liu CY, Chong CF, Lin CM, Dorji H, Teng HJ, Chang H. Establishing a clinical decision rule of severe acute respiratory syndrome at the emergency department. Ann Emerg Med 2004;43:17-22. [PMID: 14707935 DOI: 10.1016/j.annemergmed.2003.08.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
485 Hartwig SM, Holman KM, Varga SM. Depletion of alveolar macrophages ameliorates virus-induced disease following a pulmonary coronavirus infection. PLoS One 2014;9:e90720. [PMID: 24608125 DOI: 10.1371/journal.pone.0090720] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
486 Kahn JS. Epidemiology of human metapneumovirus. Clin Microbiol Rev 2006;19:546-57. [PMID: 16847085 DOI: 10.1128/CMR.00014-06] [Cited by in Crossref: 193] [Cited by in F6Publishing: 113] [Article Influence: 12.1] [Reference Citation Analysis]
487 Lin CW, Tsai CH, Tsai FJ, Chen PJ, Lai CC, Wan L, Chiu HH, Lin KH. Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti-SARS drugs. FEBS Lett 2004;574:131-7. [PMID: 15358553 DOI: 10.1016/j.febslet.2004.08.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
488 Yu H, Jiang LF, Fang DY, Yan HJ, Zhou JJ, Zhou JM, Liang Y, Gao Y, Zhao W, Long BG. Selection of SARS-coronavirus-specific B cell epitopes by phage peptide library screening and evaluation of the immunological effect of epitope-based peptides on mice. Virology 2007;359:264-74. [PMID: 17055022 DOI: 10.1016/j.virol.2006.09.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
489 Ramsey CD, Kumar A. Influenza and endemic viral pneumonia. Crit Care Clin. 2013;29:1069-1086. [PMID: 24094391 DOI: 10.1016/j.ccc.2013.06.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
490 Styra R, Hawryluck L, Robinson S, Kasapinovic S, Fones C, Gold WL. Impact on health care workers employed in high-risk areas during the Toronto SARS outbreak. J Psychosom Res. 2008;64:177-183. [PMID: 18222131 DOI: 10.1016/j.jpsychores.2007.07.015] [Cited by in Crossref: 134] [Cited by in F6Publishing: 122] [Article Influence: 9.6] [Reference Citation Analysis]
491 Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, Subbarao K, Nabel GJ. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 2004;428:561-4. [PMID: 15024391 DOI: 10.1038/nature02463] [Cited by in Crossref: 466] [Cited by in F6Publishing: 443] [Article Influence: 25.9] [Reference Citation Analysis]
492 Mansbach JM, Camargo CA Jr. Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma. Clin Lab Med 2009;29:741-55. [PMID: 19892232 DOI: 10.1016/j.cll.2009.07.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
493 Ludwig S, Zarbock A. Coronaviruses and SARS-CoV-2: A Brief Overview. Anesth Analg 2020;131:93-6. [PMID: 32243297 DOI: 10.1213/ANE.0000000000004845] [Cited by in Crossref: 70] [Cited by in F6Publishing: 47] [Article Influence: 35.0] [Reference Citation Analysis]
494 Bao M, Zhang Y, Wan M, Dai L, Hu X, Wu X, Wang L, Deng P, Wang J, Chen J, Liu Y, Yu Y, Wang L. Anti-SARS-CoV immunity induced by a novel CpG oligodeoxynucleotide. Clin Immunol 2006;118:180-7. [PMID: 16298165 DOI: 10.1016/j.clim.2005.09.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
495 Tsang KW, Mok TY, Wong PC, Ooi GC. Severe acute respiratory syndrome (SARS) in Hong Kong. Respirology 2003;8:259-65. [PMID: 14528875 DOI: 10.1046/j.1440-1843.2003.00486.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
496 Chen LL, Ou HY, Zhang R, Zhang CT. ZCURVE_CoV: a new system to recognize protein coding genes in coronavirus genomes, and its applications in analyzing SARS-CoV genomes. Biochem Biophys Res Commun 2003;307:382-8. [PMID: 12859968 DOI: 10.1016/s0006-291x(03)01192-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
497 Qin C, Wang J, Wei Q, She M, Marasco WA, Jiang H, Tu X, Zhu H, Ren L, Gao H, Guo L, Huang L, Yang R, Cong Z, Guo L, Wang Y, Liu Y, Sun Y, Duan S, Qu J, Chen L, Tong W, Ruan L, Liu P, Zhang H, Zhang J, Zhang H, Liu D, Liu Q, Hong T, He W. An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. J Pathol 2005;206:251-9. [PMID: 15892035 DOI: 10.1002/path.1769] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 4.3] [Reference Citation Analysis]
498 Zorzitto J, Galligan CL, Ueng JJ, Fish EN. Characterization of the antiviral effects of interferon-alpha against a SARS-like coronoavirus infection in vitro. Cell Res 2006;16:220-9. [PMID: 16474437 DOI: 10.1038/sj.cr.7310030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
499 Bays DJ, Nguyen MH, Cohen SH, Waldman S, Martin CS, Thompson GR, Sandrock C, Tourtellotte J, Pugashetti JV, Phan C, Nguyen HH, Warner GY, Penn BH. Investigation of nosocomial SARS-CoV-2 transmission from two patients to healthcare workers identifies close contact but not airborne transmission events. Infect Control Hosp Epidemiol 2020;:1-7. [PMID: 32618530 DOI: 10.1017/ice.2020.321] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
500 Wang ShX, Li YM, Sun BC, Zhang SW, Zhao WH, Wei MT, Chen KX, Zhao XL, Zhang ZL, Krahn M, Cheung AC, Wang PP. The SARS outbreak in a general hospital in Tianjin, China -- the case of super-spreader. Epidemiol Infect 2006;134:786-91. [PMID: 16371174 DOI: 10.1017/S095026880500556X] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
501 Skowronski DM, Petric M, Daly P, Parker RA, Bryce E, Doyle PW, Noble MA, Roscoe DL, Tomblin J, Yang TC, Krajden M, Patrick DM, Pourbohloul B, Goh SH, Bowie WR, Booth TF, Tweed SA, Perry TL, McGeer A, Brunham RC. Coordinated response to SARS, Vancouver, Canada. Emerg Infect Dis 2006;12:155-8. [PMID: 16494736 DOI: 10.3201/eid1201.050327] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
502 Zocchi E, Terrazzano G. COVID-19: why not learn from the past? Front Med 2021;15:776-81. [PMID: 34463906 DOI: 10.1007/s11684-021-0883-0] [Reference Citation Analysis]
503 Lee GOM, Warner M. Human Resources, Labour Markets and Unemployment: The Impact of the SARS Epidemic on the Service Sector in Singapore. Asia Pacific Business Review 2006;12:507-27. [DOI: 10.1080/13602380600571443] [Cited by in Crossref: 9] [Article Influence: 0.6] [Reference Citation Analysis]
504 Jang TN, Yeh DY, Shen SH, Huang CH, Jiang JS, Kao SJ. Severe acute respiratory syndrome in Taiwan: analysis of epidemiological characteristics in 29 cases. J Infect 2004;48:23-31. [PMID: 14667789 DOI: 10.1016/j.jinf.2003.09.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
505 Wang LM, Chen YC, Tung SP, Chen CY, Chang SC, Chiang SC, Lee CH. The rationale of fever surveillance to identify patients with severe acute respiratory syndrome in Taiwan. Emerg Med J 2006;23:202-5. [PMID: 16498157 DOI: 10.1136/emj.2005.027037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
506 Falzarano D, de Wit E, Martellaro C, Callison J, Munster VJ, Feldmann H. Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin. Sci Rep 2013;3:1686. [PMID: 23594967 DOI: 10.1038/srep01686] [Cited by in Crossref: 199] [Cited by in F6Publishing: 197] [Article Influence: 22.1] [Reference Citation Analysis]
507 Broor S, Bharaj P, Chahar HS. Human metapneumovirus: a new respiratory pathogen. J Biosci 2008;33:483-93. [PMID: 19208974 DOI: 10.1007/s12038-008-0067-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
508 Woo PC, Lau SK, Wong BH, Tsoi HW, Fung AM, Kao RY, Chan KH, Peiris JS, Yuen KY. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol 2005;43:3054-8. [PMID: 16000415 DOI: 10.1128/JCM.43.7.3054-3058.2005] [Cited by in Crossref: 81] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
509 Law N, Kumar D. Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management. Drugs Aging 2017;34:743-54. [PMID: 28965331 DOI: 10.1007/s40266-017-0491-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
510 Columbus C. Mad cow and other maladies: update on emerging infectious diseases. Proc (Bayl Univ Med Cent) 2004;17:411-7. [PMID: 16200129 DOI: 10.1080/08998280.2004.11928005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
511 Parashar UD, Anderson LJ. Severe acute respiratory syndrome: review and lessons of the 2003 outbreak. Int J Epidemiol 2004;33:628-34. [PMID: 15155694 DOI: 10.1093/ije/dyh198] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
512 Murdoch DR, Chambers ST. Atypical pneumonia--time to breathe new life into a useful term? Lancet Infect Dis 2009;9:512-9. [PMID: 19628176 DOI: 10.1016/S1473-3099(09)70148-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
513 Wang W, Ruan S. Simulating the SARS outbreak in Beijing with limited data. J Theor Biol 2004;227:369-79. [PMID: 15019504 DOI: 10.1016/j.jtbi.2003.11.014] [Cited by in Crossref: 111] [Cited by in F6Publishing: 64] [Article Influence: 6.2] [Reference Citation Analysis]
514 Li T, Qiu Z, Zhang L, Han Y, He W, Liu Z, Ma X, Fan H, Lu W, Xie J, Wang H, Deng G, Wang A. Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome. J Infect Dis 2004;189:648-51. [PMID: 14767818 DOI: 10.1086/381535] [Cited by in Crossref: 160] [Cited by in F6Publishing: 150] [Article Influence: 8.9] [Reference Citation Analysis]
515 Ami Y, Nagata N, Shirato K, Watanabe R, Iwata N, Nakagaki K, Fukushi S, Saijo M, Morikawa S, Taguchi F. Co-infection of respiratory bacterium with severe acute respiratory syndrome coronavirus induces an exacerbated pneumonia in mice. Microbiol Immunol 2008;52:118-27. [PMID: 18380809 DOI: 10.1111/j.1348-0421.2008.00011.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
516 Minakshi R, Padhan K. The YXXΦ motif within the severe acute respiratory syndrome coronavirus (SARS-CoV) 3a protein is crucial for its intracellular transport. Virol J 2014;11:75. [PMID: 24762043 DOI: 10.1186/1743-422X-11-75] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
517 Tse GM, Hui PK, Ma TK, Lo AW, To KF, Chan WY, Chow LT, Ng HK. Sputum cytology of patients with severe acute respiratory syndrome (SARS). J Clin Pathol 2004;57:256-9. [PMID: 14990595 DOI: 10.1136/jcp.2003.012948] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
518 Lim L, Gupta G, Roy A, Kang J, Srivastava S, Shi J, Song J. Structurally- and dynamically-driven allostery of the chymotrypsin-like proteases of SARS, Dengue and Zika viruses. Prog Biophys Mol Biol 2019;143:52-66. [PMID: 30217495 DOI: 10.1016/j.pbiomolbio.2018.08.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
519 Ye Z, Wong CK, Li P, Xie Y. A SARS-CoV protein, ORF-6, induces caspase-3 mediated, ER stress and JNK-dependent apoptosis. Biochim Biophys Acta 2008;1780:1383-7. [PMID: 18708124 DOI: 10.1016/j.bbagen.2008.07.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
520 Carman WF, Mahony JB. The pathogens. J Clin Virol 2007;40 Suppl 1:S5-S10. [PMID: 18162256 DOI: 10.1016/S1386-6532(07)70003-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
521 Neogi U, Hill KJ, Ambikan AT, Heng X, Quinn TP, Byrareddy SN, Sönnerborg A, Sarafianos SG, Singh K. Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs. Pathogens 2020;9:E320. [PMID: 32357471 DOI: 10.3390/pathogens9050320] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
522 Narayanan K, Huang C, Lokugamage K, Kamitani W, Ikegami T, Tseng CT, Makino S. Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J Virol. 2008;82:4471-4479. [PMID: 18305050 DOI: 10.1128/jvi.02472-07] [Cited by in Crossref: 248] [Cited by in F6Publishing: 194] [Article Influence: 17.7] [Reference Citation Analysis]
523 Fouchier RA, Hartwig NG, Bestebroer TM, Niemeyer B, de Jong JC, Simon JH, Osterhaus AD. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci U S A 2004;101:6212-6. [PMID: 15073334 DOI: 10.1073/pnas.0400762101] [Cited by in Crossref: 385] [Cited by in F6Publishing: 358] [Article Influence: 21.4] [Reference Citation Analysis]
524 Muller MP, Tomlinson G, Marrie TJ, Tang P, McGeer A, Low DE, Detsky AS, Gold WL. Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia? Clin Infect Dis 2005;40:1079-86. [PMID: 15791504 DOI: 10.1086/428577] [Cited by in Crossref: 71] [Cited by in F6Publishing: 53] [Article Influence: 4.2] [Reference Citation Analysis]
525 Shi X, Gong E, Gao D, Zhang B, Zheng J, Gao Z, Zhong Y, Zou W, Wu B, Fang W, Liao S, Wang S, Xie Z, Lu M, Hou L, Zhong H, Shao H, Li N, Liu C, Pei F, Yang J, Wang Y, Han Z, Shi X, Zhang Q, You J, Zhu X, Gu J. Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases. Am J Gastroenterol 2005;100:169-76. [PMID: 15654797 DOI: 10.1111/j.1572-0241.2005.40377.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 4.4] [Reference Citation Analysis]
526 Al-Tawfiq JA, Momattin H, Dib J, Memish ZA. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis. 2014;20:42-46. [PMID: 24406736 DOI: 10.1016/j.ijid.2013.12.003] [Cited by in Crossref: 200] [Cited by in F6Publishing: 185] [Article Influence: 25.0] [Reference Citation Analysis]
527 Agafonov AP, Gus'kov AA, Ternovoi VA, Ryabchikova EI, Durymanov AG, Vinogradov IV, Maksimov NL, Ignat'ev GM, Nechaeva EA, Netesov SV. Primary characterization of SARS coronavirus strain Frankfurt 1. Dokl Biol Sci 2004;394:58-60. [PMID: 15088406 DOI: 10.1023/b:dobs.0000017131.06970.74] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
528 Yeh SH, Wang HY, Tsai CY, Kao CL, Yang JY, Liu HW, Su IJ, Tsai SF, Chen DS, Chen PJ; National Taiwan University SARS Research Team. Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. Proc Natl Acad Sci U S A 2004;101:2542-7. [PMID: 14983045 DOI: 10.1073/pnas.0307904100] [Cited by in Crossref: 95] [Cited by in F6Publishing: 79] [Article Influence: 5.3] [Reference Citation Analysis]
529 Qi C, Duan JZ, Wang ZH, Chen YY, Zhang PH, Zhan L, Yan XY, Cao WC, Jin G. Investigation of interaction between two neutralizing monoclonal antibodies and SARS virus using biosensor based on imaging ellipsometry. Biomed Microdevices 2006;8:247-53. [PMID: 16718402 DOI: 10.1007/s10544-006-8305-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
530 Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci U S A 2004;101:4240-5. [PMID: 15010527 DOI: 10.1073/pnas.0306446101] [Cited by in Crossref: 383] [Cited by in F6Publishing: 356] [Article Influence: 21.3] [Reference Citation Analysis]
531 Horváth E, Rossi L, Mercier C, Lehmann C, Sienkiewicz A, Forró L. Photocatalytic Nanowires-Based Air Filter: Towards Reusable Protective Masks. Adv Funct Mater 2020;30:2004615. [PMID: 32837497 DOI: 10.1002/adfm.202004615] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 17.0] [Reference Citation Analysis]
532 Shi J, Song J. The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain. FEBS J 2006;273:1035-45. [PMID: 16478476 DOI: 10.1111/j.1742-4658.2006.05130.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 4.8] [Reference Citation Analysis]
533 Ho KY, Singh KS, Habib AG, Ong BK, Lim TK, Ooi EE, Sil BK, Ling AE, Bai XL, Tambyah PA. Mild illness associated with severe acute respiratory syndrome coronavirus infection: lessons from a prospective seroepidemiologic study of health-care workers in a teaching hospital in Singapore. J Infect Dis 2004;189:642-7. [PMID: 14767817 DOI: 10.1086/381558] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
534 de Groot-mijnes JDF, van Dun JM, van der Most RG, de Groot RJ. Natural History of a Recurrent Feline Coronavirus Infection and the Role of Cellular Immunity in Survival and Disease. J Virol 2005;79:1036-44. [DOI: 10.1128/jvi.79.2.1036-1044.2005] [Cited by in Crossref: 78] [Cited by in F6Publishing: 63] [Article Influence: 4.6] [Reference Citation Analysis]
535 Vardhana SA, Wolchok JD. The many faces of the anti-COVID immune response. J Exp Med 2020;217:e20200678. [PMID: 32353870 DOI: 10.1084/jem.20200678] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
536 Yamamoto N, Yang R, Yoshinaka Y, Amari S, Nakano T, Cinatl J, Rabenau H, Doerr HW, Hunsmann G, Otaka A, Tamamura H, Fujii N, Yamamoto N. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochem Biophys Res Commun 2004;318:719-25. [PMID: 15144898 DOI: 10.1016/j.bbrc.2004.04.083] [Cited by in Crossref: 194] [Cited by in F6Publishing: 173] [Article Influence: 10.8] [Reference Citation Analysis]
537 Makhayeva DN, Irmukhametova GS, Khutoryanskiy VV. Polymeric Iodophors: Preparation, Properties, and Biomedical Applications. Rev J Chem 2020;10:40-57. [PMID: 33362938 DOI: 10.1134/S2079978020010033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
538 Ren W, Qu X, Li W, Han Z, Yu M, Zhou P, Zhang SY, Wang LF, Deng H, Shi Z. Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin. J Virol 2008;82:1899-907. [PMID: 18077725 DOI: 10.1128/JVI.01085-07] [Cited by in Crossref: 98] [Cited by in F6Publishing: 64] [Article Influence: 6.5] [Reference Citation Analysis]
539 Desenclos JC, van der Werf S, Bonmarin I, Levy-Bruhl D, Yazdanpanah Y, Hoen B, Emmanuelli J, Lesens O, Dupon M, Natali F, Michelet C, Reynes J, Guery B, Larsen C, Semaille C, Mouton D, André M, Escriou N, Burguière A, Manuguerra JC, Coignard B, Lepoutre A, Meffre C, Bitar D, Decludt B, Capek I, Antona D, Che D, Herida M, Infuso A, Sauri C, Brücker G, Hubert B, LeGoff D, Scheidegger S. Introduction of SARS in France, March-April, 2003. Emerg Infect Dis 2004;10:195-200. [PMID: 15030682 DOI: 10.3201/eid1002.030351] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
540 Ingallinella P, Bianchi E, Finotto M, Cantoni G, Eckert DM, Supekar VM, Bruckmann C, Carfi A, Pessi A. Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus. Proc Natl Acad Sci U S A 2004;101:8709-14. [PMID: 15161975 DOI: 10.1073/pnas.0402753101] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 3.5] [Reference Citation Analysis]
541 Peiris JS. Severe Acute Respiratory Syndrome (SARS). J Clin Virol 2003;28:245-7. [PMID: 14522062 DOI: 10.1016/j.jcv.2003.08.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
542 Tambyah PA. Severe acute respiratory syndrome from the trenches, at a Singapore university hospital. Lancet Infect Dis 2004;4:690-6. [PMID: 15522681 DOI: 10.1016/S1473-3099(04)01175-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
543 Yuan J, Yun H, Lan W, Wang W, Sullivan SG, Jia S, Bittles AH. A climatologic investigation of the SARS-CoV outbreak in Beijing, China. Am J Infect Control 2006;34:234-6. [PMID: 16679182 DOI: 10.1016/j.ajic.2005.12.006] [Cited by in Crossref: 97] [Cited by in F6Publishing: 72] [Article Influence: 6.1] [Reference Citation Analysis]
544 Chathappady House NN, Palissery S, Sebastian H. Corona Viruses: A Review on SARS, MERS and COVID-19. Microbiol Insights 2021;14:11786361211002481. [PMID: 33795938 DOI: 10.1177/11786361211002481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
545 Stenseth NC, Dharmarajan G, Li R, Shi ZL, Yang R, Gao GF. Lessons Learnt From the COVID-19 Pandemic. Front Public Health 2021;9:694705. [PMID: 34409008 DOI: 10.3389/fpubh.2021.694705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
546 Mukherjee P, Desai P, Ross L, White EL, Avery MA. Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits. Bioorg Med Chem 2008;16:4138-49. [PMID: 18343121 DOI: 10.1016/j.bmc.2008.01.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
547 Vittoria BL, Imbesi C, Irene G, Calì G, Bitto A. New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection. Pharmaceuticals (Basel) 2021;14:503. [PMID: 34070359 DOI: 10.3390/ph14060503] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
548 Wan YL, Tsay PK, Cheung YC, Chiang PC, Wang CH, Tsai YH, Kuo HP, Tsao KC, Lin TY. A correlation between the severity of lung lesions on radiographs and clinical findings in patients with severe acute respiratory syndrome. Korean J Radiol 2007;8:466-74. [PMID: 18071276 DOI: 10.3348/kjr.2007.8.6.466] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
549 Liang W, Zhu Z, Guo J, Liu Z, Zhou W, Chin DP, Schuchat A; Beijing Joint SARS Expert Group. Severe acute respiratory syndrome, Beijing, 2003. Emerg Infect Dis 2004;10:25-31. [PMID: 15078593 DOI: 10.3201/eid1001.030553] [Cited by in Crossref: 56] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
550 Scales DC, Green K, Chan AK, Poutanen SM, Foster D, Nowak K, Raboud JM, Saskin R, Lapinsky SE, Stewart TE. Illness in intensive care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1205-10. [PMID: 14609453 DOI: 10.3201/eid0910.030525] [Cited by in Crossref: 111] [Cited by in F6Publishing: 97] [Article Influence: 6.2] [Reference Citation Analysis]
551 DeAlbuquerque N, Baig E, Xuezhong M, Shalev I, Phillips MJ, Habal M, Leibowitz J, McGilvray I, Butany J, Fish E, Levy G. Murine hepatitis virus strain 1 as a model for severe acute respiratory distress syndrome (SARS). Adv Exp Med Biol 2006;581:373-8. [PMID: 17037562 DOI: 10.1007/978-0-387-33012-9_66] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
552 Yan X, Hao Q, Mu Y, Timani KA, Ye L, Zhu Y, Wu J. Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein. Int J Biochem Cell Biol 2006;38:1417-28. [PMID: 16546436 DOI: 10.1016/j.biocel.2006.02.003] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 5.3] [Reference Citation Analysis]
553 Jalali-Heravi M, Asadollahi-Baboli M, Mani-Varnosfaderani A. Shuffling multivariate adaptive regression splines and adaptive neuro-fuzzy inference system as tools for QSAR study of SARS inhibitors. J Pharm Biomed Anal 2009;50:853-60. [PMID: 19665859 DOI: 10.1016/j.jpba.2009.07.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
554 Nguyen JT, Hoopes JD, Le MH, Smee DF, Patick AK, Faix DJ, Blair PJ, de Jong MD, Prichard MN, Went GT. Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro. PLoS One 2010;5:e9332. [PMID: 20179772 DOI: 10.1371/journal.pone.0009332] [Cited by in Crossref: 118] [Cited by in F6Publishing: 113] [Article Influence: 9.8] [Reference Citation Analysis]
555 Wong WC, Wong SY, Lee A, Goggins WB. How to provide an effective primary health care in fighting against severe acute respiratory syndrome: the experiences of two cities. Am J Infect Control 2007;35:50-5. [PMID: 17276791 DOI: 10.1016/j.ajic.2006.06.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
556 McAuliffe J, Vogel L, Roberts A, Fahle G, Fischer S, Shieh WJ, Butler E, Zaki S, St Claire M, Murphy B, Subbarao K. Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys. Virology 2004;330:8-15. [PMID: 15527829 DOI: 10.1016/j.virol.2004.09.030] [Cited by in Crossref: 151] [Cited by in F6Publishing: 138] [Article Influence: 8.9] [Reference Citation Analysis]
557 Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatology 2006;212 Suppl 1:119-23. [PMID: 16490989 DOI: 10.1159/000089211] [Cited by in Crossref: 196] [Cited by in F6Publishing: 167] [Article Influence: 12.3] [Reference Citation Analysis]
558 Timothy HR, Peter AC, Devilliers S, Kin LO, Alex NW. Evaluation of WHO criteria for idenfifying patients with severe acute respiratory syndrome out of hospital: prospective observational study. BMF. 2003;326:1354-1358. [PMID: 12816820 DOI: 10.1136/bmj.326.7403.1354] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 3.9] [Reference Citation Analysis]
559 Kanjanahaluethai A, Jukneliene D, Baker SC. Identification of the murine coronavirus MP1 cleavage site recognized by papain-like proteinase 2. J Virol 2003;77:7376-82. [PMID: 12805436 DOI: 10.1128/jvi.77.13.7376-7382.2003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
560 Zhao Z, Li H, Wu X, Zhong Y, Zhang K, Zhang YP, Boerwinkle E, Fu YX. Moderate mutation rate in the SARS coronavirus genome and its implications. BMC Evol Biol 2004;4:21. [PMID: 15222897 DOI: 10.1186/1471-2148-4-21] [Cited by in Crossref: 145] [Cited by in F6Publishing: 128] [Article Influence: 8.1] [Reference Citation Analysis]
561 Mahony JB, Petrich A, Louie L, Song X, Chong S, Smieja M, Chernesky M, Loeb M, Richardson S; Ontario Laboratory Working Group for the Rapid Diagnosis of Emerging Infections. Performance and Cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-pcr assays for detection of severe acute respiratory syndrome coronavirus. J Clin Microbiol 2004;42:1471-6. [PMID: 15070991 DOI: 10.1128/JCM.42.4.1471-1476.2004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
562 Sim K, Chua HC. The psychological impact of SARS: a matter of heart and mind. CMAJ 2004;170:811-2. [PMID: 14993176 DOI: 10.1503/cmaj.1032003] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 3.7] [Reference Citation Analysis]
563 Wong TW, Lee CK, Tam W, Lau JT, Yu TS, Lui SF, Chan PK, Li Y, Bresee JS, Sung JJ, Parashar UD; Outbreak Study Group. Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerg Infect Dis 2004;10:269-76. [PMID: 15030696 DOI: 10.3201/eid1002.030452] [Cited by in Crossref: 167] [Cited by in F6Publishing: 148] [Article Influence: 9.3] [Reference Citation Analysis]
564 Kwan YW, Leung CW, Chiu MC. Diarrhoea as the presenting sign in an adolescent suffering from severe acute respiratory syndrome. Eur J Pediatr 2005;164:227-30. [PMID: 15645282 DOI: 10.1007/s00431-004-1618-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
565 Khattari Z, Brotons G, Akkawi M, Arbely E, Arkin IT, Salditt T. SARS coronavirus E protein in phospholipid bilayers: an x-ray study. Biophys J 2006;90:2038-50. [PMID: 16361349 DOI: 10.1529/biophysj.105.072892] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
566 Kang X, Hu Y, Liu Z, Sarwar S. Forecast and evaluation of asymptomatic COVID-19 patients spreading in China. Results Phys 2022;34:105195. [PMID: 35070651 DOI: 10.1016/j.rinp.2022.105195] [Reference Citation Analysis]
567 Christian MD, Poutanen SM, Loutfy MR, Muller MP, Low DE. Severe acute respiratory syndrome. Clin Infect Dis 2004;38:1420-7. [PMID: 15156481 DOI: 10.1086/420743] [Cited by in Crossref: 137] [Cited by in F6Publishing: 113] [Article Influence: 7.6] [Reference Citation Analysis]